
==== Front
BMC Med
BMC Med
BMC Medicine
1741-7015
BioMed Central London

39278907
3617
10.1186/s12916-024-03617-3
Review
Prenatal environmental risk factors for autism spectrum disorder and their potential mechanisms
Love Chloe 12
Sominsky Luba 12
O’Hely Martin 23
Berk Michael 2
Vuillermin Peter 123
Dawson Samantha L. samantha.dawson@deakin.edu.au

234
1 https://ror.org/00my0hg66 grid.414257.1 0000 0004 0540 0062 Child Health Research Unit, Barwon Health, Geelong, Australia
2 https://ror.org/02czsnj07 grid.1021.2 0000 0001 0526 7079 The Institute for Mental and Physical Health and Clinical Translation (IMPACT), Deakin University, Geelong, Australia
3 https://ror.org/048fyec77 grid.1058.c 0000 0000 9442 535X Murdoch Children’s Research Institute, Parkville, Australia
4 https://ror.org/02czsnj07 grid.1021.2 0000 0001 0526 7079 Food and Mood Centre, Deakin University, Geelong, Australia
16 9 2024
16 9 2024
2024
22 3933 3 2024
5 9 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Autism spectrum disorder (ASD) is a neurodevelopmental disorder that is globally increasing in prevalence. The rise of ASD can be partially attributed to diagnostic expansion and advocacy efforts; however, the interplay between genetic predisposition and modern environmental exposures is likely driving a true increase in incidence. A range of evidence indicates that prenatal exposures are critical. Infection during pregnancy, gestational diabetes, and maternal obesity are established risk factors for ASD. Emerging areas of research include the effects of maternal use of selective serotonin reuptake inhibitors, antibiotics, and exposure to toxicants during pregnancy on brain development and subsequent ASD. The underlying pathways of these risk factors remain uncertain, with varying levels of evidence implicating immune dysregulation, mitochondrial dysfunction, oxidative stress, gut microbiome alterations, and hormonal disruptions. This narrative review assesses the evidence of contributing prenatal environmental factors for ASD and associated mechanisms as potential targets for novel prevention strategies.

Keywords

Autism spectrum disorder
Autism
Prenatal factors
Early life exposures
Etiology
Epidemiology
Biomarkers
Mental health
Psychiatry
issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2024
==== Body
pmcBackground

Autism spectrum disorder (ASD) is an umbrella term for a heterogeneous group of neurodevelopmental disorders characterized by deficits in social communication, repetitive and stereotypical behaviors, and intellectual disabilities of varying levels [1]. ASD characteristics persist throughout life but are primarily diagnosed during early childhood when atypical developmental trajectories emerge [2]. A recent systematic review of 71 studies estimated the global median prevalence of ASD between 2012 and 2022 to be 10 per 1000 children and adults [3]. Males are approximately 4.2 times more likely to be affected than females [3], with differences in social communication, camouflaging, and restrictive and repetitive behaviors evident between the sexes [4].

The etiology of ASD is multifactorial, shaped by inherited genetics, environmental contributions—particularly those associated with the maternal environment—and intricate gene–environment interactions [5, 6]. Epidemiological studies indicate that potential environmental prenatal factors contributing to ASD include exposure to infection during pregnancy, obesity, gestational diabetes mellitus (GDM), maternal selective serotonin reuptake inhibitor (SSRI) use, antibiotic use, and prenatal exposure to toxicants [7–12]. These prenatal factors may alter several pathways during critical developmental periods [13], particularly in genetically sensitive individuals [14]. The evidence relating to the potential pathways underlying the aforementioned prenatal factors is largely preclinical and implicates immune dysregulation, mitochondrial dysfunction, oxidative stress, gut microbiome alterations, and hormonal disruptions [15–19]. Understanding the complex etiology of ASD and underlying pathways may help identify early biomarkers and targets for primary prevention. While previous reviews have explored various genetic and prenatal factors associated with ASD risk [20, 21], here, we assess the current evidence for potentially modifiable prenatal environmental risk factors for ASD, as outlined in Fig. 1. We discuss potential mechanisms underlying each specific risk factor, particularly expanding on the role of the gut microbiome.Fig. 1 A schematic diagram summarizing prenatal environmental risk factors for autism spectrum disorder (ASD) and their potential mechanisms. From left to right, the left panel outlines genetic susceptibility and prenatal environmental risk factors such as infection during pregnancy, maternal obesity, diabetes, selective serotonin reuptake inhibitor (SSRI) and antibiotic use, and exposure to toxicants. The central panel details the underlying mechanisms for these risk factors, including inflammation, mitochondrial dysfunction, hormonal disruption, oxidative stress, and alterations in the gut microbiome that are associated with ASD development in offspring depicted in the panel on the right

Genetic predisposition

Many genes and gene variants likely contribute to ASD [22]. The high concordance of ASD in monozygotic twins, increased sibling recurrence, and familial aggregation of ASD suggest a strong genetic component, with heritability estimated to be approximately 50% [23–26]. The presence of autistic traits in genetically defined disorders, such as fragile X syndrome and Rett syndrome, supports the importance of genetic contributions to ASD more generally [27]. Sex differences in autism may arise due to differential genetic penetrance, sex-specific loci, or genetic mutations [28, 29]. Sex-specific phenotypic changes may begin via epigenetic interactions in utero through altered hormone exposure influencing endocrine function and neurodevelopment [30, 31]. A genetic predisposition to ASD may increase susceptibility to inflammation, mitochondrial dysfunction, oxidative stress, alterations in the gut microbiome, and hormone disruption, which may collectively underlie the connection between prenatal factors and ASD development [17, 32]. However, the clinical heterogeneity of ASD, including sexual dimorphism, behavioral phenotype distinctions, and individual developmental progression, makes it challenging to ascertain underlying genetic variations and pathophysiology [33].

Infection during pregnancy

Several studies have established an association between infections such as rubella [34, 35] and cytomegalovirus [36] during pregnancy and an increased likelihood of ASD in children [8, 37], consistent with the findings from preclinical studies investigating the role of maternal infection in ASD-like behavior in offspring [38]. A Danish population study found that viral infections including influenza, gastroenteritis, and other unspecified viral infections in the first trimester of pregnancy requiring hospitalization correlated with a 2.8-fold increase in the risk of ASD, while bacterial infections in the second trimester were associated with a 1.4-fold increase [39]. In the same cohort, exposure to only influenza during pregnancy was associated with a 2.3-fold increase in the risk of ASD, regardless of the trimester of exposure [40]. A meta-analysis of 36 studies revealed that any maternal infection or fever was associated with a 1.3-fold increase in ASD development [8]. Fever during pregnancy was associated with a 2.1-fold increase in the odds of ASD, independent of infection; however, these findings were attenuated in mothers who reported taking antipyretic medications to prevent or reduce fever, suggesting antipyretics may modify the relationship between infection and ASD [41]. A Danish population-based genome-wide association study found an association between the genetic profile of mothers with a history of any infection during pregnancy and subsequent ASD compared to the genetic profile of mothers with no history of infections during pregnancy [42]. While the reported genetic association between a history of maternal infection and ASD was relatively low, these maternal infection–based cases of ASD may have distinct genetic aetiologies. Validation of infection sites, types and timing during pregnancy poses a challenge, limiting the accurate evaluation of maternal infection’s role in ASD development. Further research is needed to distinguish the direct pathogenic effects of infection from the indirect effects of inflammation during pregnancy.

Potential mechanisms

Inflammation

Maternal immune activation (MIA), triggered by infection or inflammation during pregnancy, has been associated with a range of developmental difficulties in children, including increased risk of speech, language, and motor delays [43], increased behavioral and emotional problems [44] and altered connectivity in brain regions supporting working memory in children [45]. MIA elevates circulating and central proinflammatory cytokines in animal models, potentially impacting fetal immunity and neurodevelopment [46, 47]. Offspring of mice exposed to MIA during pregnancy exhibit heightened neuroinflammation and display ASD-like impaired inhibition and social interaction behaviors [48]. Maternal cytokines may cross the placenta, enter fetal circulation, and activate the fetal immune system [49, 50]. The placenta expresses all ten functional toll-like receptors, in humans and can therefore directly recognize microbial products, leading to increased placental inflammation and inflammatory cytokine release, affecting fetal brain development [51]. As such, administration of bacterial mimetic lipopolysaccharide (LPS) to pregnant mice on embryonic day 14 increases maternal circulating levels of interleukin (IL)-17, a T cell-derived proinflammatory cytokine, and subsequently leads to increased ASD-like impaired vocalization and social approach behaviors in their offspring [52]. Administration of IL-17-blocking antibodies prior to LPS prevented such behaviors [53]. In the poly(I:C) MIA mouse model, an increase in inflammatory cytokine concentration in maternal serum and amniotic fluid is associated with subsequent ASD-like deficits in inhibition control and exploratory and social behaviors in the offspring [54]. IL-6, a key proinflammatory cytokine, has been shown to play a critical role in promoting MIA-induced ASD-like deficits in inhibition control and social interaction in mice [48]. In addition to maternal IL-6 being able to cross the placenta and influence the fetus directly [55], there is also evidence that placental IL-6 signaling in response to MIA results in acute immune activation in the fetal brain and subsequent behavioral impairments [54]. In mice, blocking placental IL-6 signaling prevents MIA-induced immune activation in the fetal brain and subsequent behavioral abnormalities [54]. Elevated gene expression of IL-6 has also been observed in the brains of MIA-exposed mice and in the brain tissue of autistic individuals [56]. It is likely that concurrent risk factors or repeat infections are relevant to ASD susceptibility [57]. Adequate maternal levels of vitamins and antioxidants may enhance resilience to the effects of MIA [58], potentially influencing the effects of MIA on ASD development.

Mitochondrial function

Mitochondria are highly sensitive to immune and intrauterine changes and may mediate the relationship between infection-related inflammatory responses and ASD development [16]. A recent review identified 12 preclinical studies providing evidence for MIA-inducing ASD-like altered inhibitory and social behavior, sensorimotor coordination in offspring, and changes in brain mitochondrial morphology, density, and oxidative stress levels [59]. Exposure to LPS has been shown to increase reactive oxygen species (ROS) production [60] and lead to metabolic reprogramming from oxidative phosphorylation to glycolysis, particularly in microglia, the primary innate immune cells in the brain [61]. In addition to being a target of MIA, mitochondrial molecules, including adenosine triphosphate, mitochondrial DNA, and ROS, can also lead to inflammatory responses, directly influencing neuroinflammation [62]. Given the critical role of mitochondrial function in brain development, including neurogenesis, synaptogenesis, glial cell development and other processes with high bioenergetic requirements, MIA-induced disruption in mitochondrial bioenergetics during this critical period has major implications for neurodevelopment [59]. Preclinical models suggest the potential reversibility of MIA insults by redox modifiers such as N-acetylcysteine [63]. Human postmortem tissue studies have shown decreased expression of mitochondrial genes in regions involved in emotion and behavior regulation and motor function in autistic brains compared to non-autistic individuals [64]. Positron emission tomography (PET) scanning identified mitochondrial dysfunction in multiple brain regions in 23 adult autistic males compared to 24 age- and sex-matched nonautistic individuals [65]. Reduced mitochondrial function correlated with more severe social communication challenges in males, indicating a potential association between specific brain areas and core ASD characteristics [65]. The small sample size limits exploration of mitochondrial function using PET scanning and the study has yet to be repeated in females.

Gut microbiome

In preclinical studies, changes in the maternal gut microbiome during pregnancy mediate the effects of maternal infection on ASD development. The offspring of influenza A virus (IAV)-infected mice exhibited impaired mucosal immunity and altered immune cell profiles within gut-associated lymphoid tissue [66]. As IAV does not directly infect the fetus or placenta [67], this response may occur due to changes in the maternal immune system or potentially be mediated via the gut microbiota, which can influence early life immune development [66]. Offspring of the poly(I:C) MIA mouse model show ASD-like communicative, social, and stereotypic impairments alongside differences in the gut microbiome profile and increased intestinal permeability [18]. Oral administration of Bacteroides fragilis to MIA pups reduced gut permeability and ameliorated ASD-like anxiety, sensorimotor, repetitive, communicative, and social behaviors [18], suggesting that therapies targeting the gut microbiome may improve ASD-like behavioral symptoms. Mothers of children with ASD have more Proteobacteria, Alphaproteobacteria, Moraxellaceae, and Acinetobacter than mothers of children without ASD and that these microbiome profiles are associated with their children’s microbiome [68]. The role of the gut microbiome as a mediator between maternal infection and ASD development has yet to be explored in humans.

Infection during pregnancy induces inflammation, disrupting inflammatory pathways, and mitochondrial and gut microbiome function. While each pathway may play a distinct role in ASD development, there is likely a cumulative effect from multidirectional interactions between multiple pathways (Table 1). Variability in assessing acute and chronic inflammation highlights the necessity for standardized biomarkers and laboratory techniques to assess inflammatory responses. Table 1 Summary of key studies of maternal environmental risk factors for ASD and underlying mechanisms

	Maternal environmental exposures	
Potential mechanisms	Maternal infection	Maternal obesity and GDM	Maternal SSRI use	Maternal antibiotic Use	Exposure to toxicants	
Inflammation	↑ maternal immune activation [46, 47]a, [43–45]b

↑ maternal proinflammatory cytokine release [46, 47, 54]a

↑ maternal IL-6 [47, 48]a

↑ maternal IL-17 [52]a

↑ placental IL-6 [49, 54, 55]a

	↑ maternal proinflammatory cytokine release [69]a

↑maternal IL-6 [70]a

↑ maternal IL-1β [71, 72]a

↑ maternal TNF-α [71]a

↑ offspring IL-1β [73]a

↑ offspring TNF-α [73]a

	↑ maternal immune activation [74]a

↑ maternal whole blood serotonin levels [74]a

	↑ maternal immune activation [15]a, [75]a

↑ maternal IL-17 [75]a

↑ maternal T helper 17 cells [75]a

	↑ offspring IL-1β [76]a

Altered maternal TLR-4 expression [77]a

	
Mitochondrial dysfunction	Altered offspring mitochondrial morphology and density [59]a

Altered mitochondrial function [65]b

↓ mitochondrial gene expression [64]c

↑ ROS [60]a

		Altered maternal mitochondrial function [78, 79]a		Altered maternal mitochondrial function [16]a	
Gut microbiome	↑ maternal intestinal permeability [18]a

Altered maternal microbiome composition [18]a

↓ maternal mucosal immunity [66]a

Altered maternal GALT immune cell profiles [66]a

	↑ maternal intestinal permeability [72, 80]b

altered maternal gut microbiome composition [80, 81]b

altered maternal SCFA release [82, 83]a

maternal LPS translocation [84, 85]b

	Altered SCFA release [86]a,c

altered serotonin production [86]a,c

Altered offspring serotonin production [87]a

	↑ maternal intestinal permeability [88]a

↑ maternal LPS translocation [88]a

		
Hormone disruption		↑ maternal leptin [89]a, [90]b			Fetal testosterone disruption [91]a

↓ offspring neuroestrogen production [92]a

	
Oxidative stress	↑ maternal oxidative stress [59]a		↑ offspring oxidative stress [93]a		↑ maternal non-oxidative energy metabolism [94]b

↑ child oxidative stress genetic score [95]b

↑ child oxidative stress-related SNPs [95]b

	
GALT gut-associated lymphoid tissue, IL interleukin, LPS lipopolysaccharide, ROS reactive oxygen species, SCFA short-chain fatty acid, SNPs single nucleotide polymorphisms, TLR toll-like receptor, TNF tumor necrosis factor

aIndicates animal studies

bindicates human studies

cindicates in vitro studies

Maternal obesity and GDM

Maternal obesity and GDM are both linked to an increased likelihood of ASD in children. Several epidemiological studies have shown that pre-pregnancy obesity increases the odds of ASD in children by 1.3–2.0-fold [7]. Additionally, excessive gestational weight gain on its own increases the odds for ASD in children by 1.1–1.6-fold [7]. A meta-analysis of 12 studies found that GDM was associated with a 1.5–1.7-fold increase in the risk for ASD in children compared to mothers without GDM [96]. Pre-existing type 2 diabetes is also associated with a 1.3-fold increase in the risk of ASD in children, and GDM is associated with a 1.4-fold increase when diagnosed at 26 weeks gestation or earlier [97]. No association between GDM and ASD development was detected when GDM was diagnosed after 26 weeks [97], indicating that the timing of GDM onset may be important.

Potential mechanisms

Inflammation

Both obesity and GDM are well-known inflammatory conditions and can lead to a dysregulated immune system, which may subsequently impair fetal neurodevelopment and increase ASD susceptibility [98]. Preclinical findings demonstrate that systemic inflammation induced by maternal obesity and GDM leads to an increased release of maternal proinflammatory cytokines that cross the placenta and alter the fetal development of neural pathways that regulate behavior [69]. Pregnant rats were administered streptozotocin, a diabetes-inducing agent, leading to elevated levels of inflammatory cytokines IL-1β and tumor necrosis factor (TNF)-α in the brain tissue of their offspring, accompanied by neurodevelopmental delays in behavioral tasks [73]. Exposure to a high-fat diet during pregnancy in rodents also increases local and systemic inflammation and the production of the proinflammatory cytokines, including IL-1β, IL-6, and TNF-α in maternal and offspring serum and brain, increasing atypical anxiety, cognitive and social behaviors in the offspring [70–72].

Hormonal disruption

Obesity and GDM may promote hormonal changes in women during pregnancy influencing maternal weight, glucose metabolism, and immune function [89, 97]. Consequently, obesity and GDM may disrupt the interaction between maternal metabolic hormones such as leptin and insulin [90, 99], leading to heightened secretion of inflammatory cytokines [100]. The dysregulation of metabolic hormones and cytokine secretion can be transmitted from mother to fetus, influencing the development of brain regions and neural circuitry associated with energy balance and behavior regulation [101]. Additionally, maternal and fetal metabolic hormone changes can shape the developing brain and may contribute to sexually dimorphic characteristics and behaviors [102, 103]. Mouse and human studies indicate that placental immune responses may occur in a sex-specific manner in response to maternal stressors, potentially mediated by hormonal disruptions and consequently influencing neurodevelopmental outcomes [104, 105]. However, whether placental immune activation has a causal role or reflects fetal brain immune activation in response to maternal obesity and diabetes has yet to be established, as has whether these responses reflect sex-specific ASD characteristics.

Gut microbiome

Obesity and GDM in women during pregnancy can alter the gut microbiota composition [80, 81] and lead to inflammation in the gut mucosa and impaired gut barrier integrity [72, 80]. An impaired gut barrier can result in the translocation of the mother’s gut microbiota and its by-products such as proinflammatory cytokines and LPS, into the placenta [84, 85]. In mice, depletion of the maternal gut microbiota inhibits placental growth and vascularisation, modulating metabolite circulation [82]. Supplementation with short-chain fatty acids (SCFAs) prevents the inhibition of placental growth and vascularisation, highlighting the crucial role of the maternal gut microbiome in early placental structure and function [82]. By contrast, the administration of neurotoxic levels of the SCFA propionic acid to pregnant mice induced ASD-like social, anxiety, and repetitive behaviors, which were alleviated by sodium butyrate, indicating gut-derived metabolites may have complex effects on ASD-like behavioral outcomes [83]. Neurotoxic levels of propionic acid also induced ASD-like behaviors in neonatal rats born to mothers with type 1 diabetes, and insulin therapy in the mothers mitigated ASD-like social and communication behaviors in offspring [106], highlighting the impact of hyperglycemia on offspring ASD and the potential benefits of insulin therapy during pregnancy.

Further investigation is needed to explore the relationship between obesity, GDM, and ASD, as well as potential underlying pathways, particularly in human cohorts. Discrepancies in epidemiological evidence may stem from variations in body mass index profiles and diabetes types considered. The co-occurrence of obesity and GDM, given their shared metabolic features and inflammatory profiles, complicates the assessment of their respective roles in ASD development, with the combined effect of maternal obesity and diabetes likely exerting a greater influence on ASD outcomes than either condition alone. Investigating the individual and combined contribution of obesity and GDM is crucial for identifying unique and shared underlying pathways. Prenatal dietary interventions targeting gut microbiota-derived inflammation could reduce the effect of maternal obesity and GDM on ASD development.

Maternal SSRI use

Evidence from epidemiological studies suggests that prenatal use of SSRI antidepressants is associated with a 1.5–4.5-fold increase in the risk for ASD in children, compared to children not exposed to SSRIs [11, 107–109]. This risk appears to be influenced at least to some extent by the trimester of pregnancy during which exposure to SSRIs occurred, with the highest odds of ASD development being for children of mothers with SSRI use during the first trimester [110, 111]. This timing of vulnerability to the effects of SSRIs coincides with the period of active organogenesis occurring between weeks three and eight of gestation, being also the critical period for ASD development in children of women exposed to potent teratogens, such as valproic acid and thalidomide [112, 113]. The association between prenatal SSRI use and ASD risk is attenuated when controlled for pre-existing psychiatric conditions [114], suggesting confounding by indication. Further, the significant association of preconception-only use of SSRIs, defined as occurring from 3 months prior to conception, and the risk of ASD in children, suggests that confounding by indication is likely involved [110]. Given the relatively short half-lives of SSRIs, except fluoxetine which can still be biologically active after five or more weeks of cessation [115], the mechanisms underlying the association between preconception exposure to SSRIs and ASD development are unclear. Additional population-based studies are required to improve the current understanding of risks versus benefits associated with SSRIs and other antidepressants used during pregnancy, particularly given the high risk of ASD development in children of mothers with psychiatric disorders [116].

Potential mechanisms

SSRI use during pregnancy may alter fetal serotonin system development, impair mitochondrial and gut microbiome function, and elevate oxidative stress [87, 93]. SSRIs act by inhibiting serotonin uptake centrally and peripherally [117]. During pregnancy, there is a substantial increase in peripheral serotonin production. In addition to gut enterochromaffin cells [118], the pancreas also contributes to increases in maternal serotonin levels during pregnancy [119], while placental production of serotonin contributes to the fetal brain serotonin concentration [120]. The serotonin system is critical for neurodevelopment, and its disruption has been implicated in ASD development, with elevated whole blood serotonin levels being consistently found in people with ASD [74]. High blood levels of serotonin in mothers exposed to SSRIs could therefore result in disrupted serotonin functioning in the fetal brain, leading to neurodevelopmental abnormalities [121]. Preclinical studies have shown that using SSRIs modulates mitochondrial function by affecting the activity of mitochondrial enzymatic complexes involved in the electron transport chain and the process of oxidative phosphorylation [78, 79]. While some studies have shown positive effects of certain SSRIs on the activities of individual enzymatic complexes or respiration analysis indicative of mitochondrial dysfunction, others have reported negative or divergent effects [79], with prenatal exposure potentially contributing to changes in neonatal energy metabolism [122]. It is, however, important to note that these conclusions are based on outcomes in animal studies, with almost no human data available. The gut microbiome is also essential for serotonin production, and gut microbes acting through short-chain fatty acids have been shown to modulate serotonin production in preclinical and in vitro human models [86]. Alterations in serotonin signaling observed in individuals with ASD following SSRI use may therefore be mediated by SSRI-induced changes in the gut microbiome [118, 123].

Epidemiological studies are needed to establish causal pathways between maternal SSRI use and ASD development. Isolating the direct impact of SSRIs is complex due to the interplay of depression, potential comorbidities, and lifestyle factors as well as the need to account for confounders like past maternal mental illness and timing of SSRI exposure. Studies of SSRI use may be influenced by indication bias, as the reasons for usage may affect the biological mechanisms underpinning ASD.

Maternal antibiotic use

Maternal antibiotic use during pregnancy may increase the likelihood of ASD, with 1.1–1.5-fold increases in the risk of ASD reported across several international cohorts after prenatal antibiotic exposure [12, 124, 125]. A prospective birth cohort showed that among women who received antibiotics during pregnancy, influenza in the second trimester was not associated with ASD development in children. For women who were not exposed to an antibiotic at any point during pregnancy, influenza in the second trimester was associated with a 4.0-fold increase in the odds of ASD, indicating that antibiotic use may modify the influence that maternal influenza has on ASD development [126]. Notably, adjusting for the type of antibiotic prescribed and using sibling-matched cohorts to account for unmeasured familial environmental and genetic confounders attenuated many of these findings. Studies on antibiotic use, like those on SSRIs, are often confounded by indication and include any exposure to antibiotics. Prospective cohort studies may help determine whether observed effects are due to antibiotics or underlying infections.

Potential mechanisms

Mouse models have demonstrated that antibiotic use can modify MIA’s effect on offspring neurodevelopmental outcomes, leading to behavioral abnormalities [15]. Antibiotic use can increase gut permeability [88], resulting in increased systemic translocation of the maternal gut microbiota and its by-products, such as LPS, into the placenta and fetal gut [88]. This, in turn, can impact fetal immunity or induce epigenetic changes by releasing SCFAs [88]. The administration of the broad-spectrum antibiotic vancomycin to pregnant poly(I:C) MIA mice altered the gut microbiota composition, resulting in reduced intestinal T helper 17 cell levels and decreased IL-17a in the maternal plasma, preventing reduced sociability, increased repetitive behaviors, and abnormal communication typically observed in the offspring of mice receiving MIA manipulation [75]. While these findings conflict with evidence that antibiotic use may contribute to ASD development, the presence of commensal bacteria that are sensitive to vancomycin may be necessary for the prevention of MIA-associated behavior in the offspring [75]. It is noteworthy that experimental antibiotic administration in rodents differs greatly from human usage in terms of types, dosages, treatment durations, and underlying conditions and reason for administration. Additionally, existing gut microbiome composition, immune response, and infection susceptibility vary due to species-specific physiology and future studies should consider these factors.

Maternal exposure to toxicants

Prenatal exposure to toxicants such as phthalates, air pollutants, and heavy metals may disrupt the endocrine system and increase inflammation, altering downstream neurodevelopment and increasing ASD likelihood [127]. Exposure to plasticizers such as phthalates measured in prenatal urine samples has been associated with higher ASD symptom scores in several epidemiological studies [10, 128, 129]. Prenatal air pollution exposure was also associated with a 2.2-3.6 increase in ASD risk in children in several large-scale epidemiological studies [130, 131], while a meta-analysis of 28 studies revealed that maternal exposure to air pollution was associated with a 1.4-fold increase in the risk of ASD in newborns [132]. A meta-analysis of two longitudinal cohort studies found that an increase in maternal concentrations of the heavy metals cadmium and cesium were both associated with a 1.8-fold increase in the risk of ASD [133]. A systematic review of 53 studies revealed higher lead and mercury concentrations in autistic individuals compared to non-autistic individuals [134]. However, significant geographical and metal detection heterogeneity among studies included in the meta-analysis highlights the need for future longitudinal studies with harmonized designs, measures, and analysis strategies. Evidence for an association between prenatal pesticide exposure and ASD is emerging but limited by variability in pesticide types [135–137], measurement methods, and exposure levels [138] between studies and there are few preclinical studies.

Potential mechanisms

The accumulation of persistent organic and heavy metal pollutants may act synergistically via alterations in hormonal pathways, inflammation, and oxidative stress, leading to neurotoxic effects during critical prenatal and early postnatal periods. Preclinically, stronger associations between maternal toxicant exposure and social impairment are often observed in males [139]. Stronger associations in males suggest a sex-specific interaction, potentially mediated by a hormone imbalance as maternal toxicant exposure can disrupt testosterone activity in the fetus [91]. By mimicking or interfering with hormone production or homeostasis, toxicants may influence sexually dimorphic aspects of neurodevelopment and subsequent social behaviors [139]. Further, bisphenol A exposure during pregnancy also increases male infants’ risk of ASD via downregulating methylation (silencing) of the brain aromatase gene, leading to decreased neuroestrogen production [92]. A large birth cohort study has demonstrated elevated prenatal di-(2-ethylhexyl) phthalate (DEHP) levels to be associated with increased ASD symptoms at 2 and 4 years, potentially mediated by a metabolic shift in pregnancy toward nonoxidative energy pathways [94]. Higher prenatal phthalate levels and a higher oxidative stress genetic score are associated with subsequent ASD, with oxidative stress-related single nucleotide polymorphisms (SNPs) modifying the prenatal phthalate and ASD association [10, 95]. Autistic children may metabolize toxicants differently [140], possibly due to epigenetic modifications that affect mechanisms underlying genetic susceptibility to toxicant exposure. Alteration in the genes that encode the proteins responsible for the breakdown of toxicants is one biologically plausible mechanism [141].

Diesel exhaust particles (DEPs), a primary toxic component of air pollution have been linked to ASD-like vocalization and social behavior deficits potentially mediated by dysregulated prenatal toll-like receptor (TLR)‑4 expression [77]. Prenatal exposure to DEPs in TLR-4 knockout mice induced neuroinflammation, delayed microglial maturation, and increased the levels of the inflammatory cytokine IL-1β, potentially linking DEP exposure to ASD development through immune dysregulation [76]. Heavy metals may also alter glutathione antioxidant capability, which has been found in individuals with ASD [142]; however, the relationship between maternal exposure to heavy metals and ASD development is not well understood in humans, and even less is known about the underlying mechanisms.

Research on the role of toxicants such as phthalates, air pollutants, and heavy metals in ASD development is still in its infancy and requires further investigation. To explore the underlying pathways, toxicant biomarkers are frequently measured in blood, urine, or hair. Assessing the accumulation of toxicants may benefit from using brain or tooth samples as they represent the tissue where toxicants are deposited [131]; however, obtaining these samples can be challenging, with brain tissue notably harder to collect than teeth.

Future directions

The last decade has seen major advances in identifying prenatal risk factors for ASD including exposure to infection, GDM, and obesity [7–9, 143], while the potential impacts of SSRI use, antibiotic use and exposure to toxicants are emerging fields of research [10–12]. Exploration of mechanisms underlying ASD such as immune dysregulation, gut microbiome alterations, hormonal disruption, mitochondrial dysfunction, and oxidative stress is predominantly preclinical. Transitioning preclinical findings into epidemiological studies is required to strengthen the evidence of pathways underpinning ASD and to identify potential targets for novel prevention strategies.

ASD is phenotypically and genetically heterogeneous, with the former creating diagnostic and classification challenges and the latter leading to a range of sensitivities to environmental risk factors, potentially masking relevant associations. ASD frequently co-occurs with other conditions and shares overlapping social, cognitive, and behavioral characteristics with ADHD, mood, and psychiatric disorders [144, 145]. Understanding how prenatal risk factors for ASD influence these shared characteristics may provide insights into related conditions. Improvement in the definition of ASD subgroups may reduce the diluting impact of case misclassification. Latent class analysis is a statistical method that can be used to identify ASD subgroups agnostically by analyzing the behavior and social traits of autistic individuals, to identify subgroups based on the severity of characteristics, co-occurring conditions, developmental trajectories, and potential responses to intervention strategies. Applying latent class analysis may increase our understanding of ASD heterogeneity and help identify biological pathways and treatment targets relevant to specific subgroups, thus enabling personalized management plans and improved outcomes for autistic individuals. The use of genetic susceptibility scores, like those evaluating the role of genetic predisposition to oxidative stress in ASD pathogenesis [95], may lead to an improved understanding of genetic susceptibility to environmental risk factors and their underlying biological processes [95]. Genetic susceptibility scores capturing the transcriptional activity of response pathways beyond oxidative stress may provide novel genetic markers of mechanisms associated with ASD development.

To address challenges in identifying causal pathways in epidemiological research, sufficiently large and detailed longitudinal birth cohort studies are needed to develop a comprehensive understanding of the impact of non-etiological factors and prenatal and early life risk factors on the developmental trajectory of ASD. Epidemiological studies must employ robust clinical phenotyping of the diverse spectrum of autistic traits and behaviors and integrate highly dimensioned multi-omic methodologies to offer valuable insights into the mechanisms underlying ASD. The exposome approach, which describes all an individual's environmental exposures throughout life, beginning with prenatal development [146], may contextualize multi-omic methods and enhance our understanding of gene–environment interactions on health outcomes, such as ASD development.

Epidemiological research must thoroughly consider potential confounding and mediating factors across pregnancy and early life. Complementing epidemiological findings with preclinical research is essential for testing causality and conducting more invasive investigations into the mechanisms underlying ASD development. Further research exploring the causation of ASD should examine maternal and early-life genetic and environmental contributors, focusing on identifying points of confluence in overlapping biological pathways to uncover predictive biomarkers and targets for early primary prevention.

Conclusions

ASD is a growing public health challenge, where the interplay between genetic predisposition and modern environmental exposures, notably the prenatal environment, plays a substantial role. Infection, obesity, GDM, SSRI use, antibiotics, and exposure to toxicants during pregnancy may all influence inflammation, hormonal balance, mitochondrial function, and the gut microbiome to disrupt subsequent neurodevelopment. Further, underlying pathways may interact, leading to cumulative effects on ASD risk. Understanding the interplay between genetics and the prenatal environment in ASD etiology and identifying modifiable points of confluence between multiple pathways, is crucial to developing novel and effective public health policies aimed at reducing prenatal exposure to risk factors in susceptible populations.

Abbreviations

ASD Autism spectrum disorder

DEPs Diesel exhaust particles

DEHP Di-(2-ethylhexyl) phthalate

GDM Gestational diabetes mellitus

IAV Influenza A virus

IL Interleukin

LPS Lipopolysaccharide

MIA Maternal immune activation

PET Positron emission tomography

SCFAs Short-chain fatty acids

SNPs Single nucleotide polymorphisms

SSRIs Selective serotonin reuptake inhibitors

TNF Tumor necrosis factor

Acknowledgements

We acknowledge the lived experience of neurodivergent people and their contribution to humanity. We are aware that some individuals may prefer identity-first language while others may prefer person-first language; we use both in this paper. Figure 1 was created with BioRender.com.

Authors’ contributions

CL and SD designed and conceived this manuscript. CL wrote the manuscript with major contributions from SD. LS made substantial contributions regarding maternal SSRI use. LS, MOH, MB and PV critically revised the manuscript and contributed to the final draft. All authors read and approved the final manuscript.

Funding

MB is supported by a NHMRC Leadership 3 Investigator grant (GNT2017131). Samantha Dawson was supported by an Alfred Deakin Postdoctoral Research Fellowship and is currently supported by a Medical Research Future Fund grant (MRFF 2025947). No other funding directly contributed to this manuscript.

Availability of data and materials

Not applicable.

Data availability

No datasets were generated or analysed during the current study.

Declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2013 5
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. 2013.
2. Hyman SL Levy SE Myers SM Kuo DZ Apkon S Davidson LF Identification, evaluation, and management of children with autism spectrum disorder Pediatrics 2020 145 1 e20193447 10.1542/peds.2019-3447 31843864
Hyman SL, Levy SE, Myers SM, Kuo DZ, Apkon S, Davidson LF, et al. Identification, evaluation, and management of children with autism spectrum disorder. Pediatrics. 2020;145(1):e20193447.31843864 10.1542/peds.2019-3447
3. Zeidan J Fombonne E Scorah J Ibrahim A Durkin MS Saxena S Global prevalence of autism: a systematic review update Autism Res 2022 15 5 778 790 10.1002/aur.2696 35238171
Zeidan J, Fombonne E, Scorah J, Ibrahim A, Durkin MS, Saxena S, et al. Global prevalence of autism: a systematic review update. Autism Res. 2022;15(5):778–90.35238171 10.1002/aur.2696
4. Ratto AB Kenworthy L Yerys BE Bascom J Wieckowski AT White SW What about the girls? Sex-based differences in autistic traits and adaptive skills J Autism Dev Disord 2018 48 5 1698 1711 10.1007/s10803-017-3413-9 29204929
Ratto AB, Kenworthy L, Yerys BE, Bascom J, Wieckowski AT, White SW, et al. What about the girls? Sex-based differences in autistic traits and adaptive skills. J Autism Dev Disord. 2018;48(5):1698–711.29204929 10.1007/s10803-017-3413-9
5. Hansen SN Schendel DE Parner ET Explaining the Increase in the prevalence of autism spectrum disorders JAMA Pediatr 2015 169 1 56 10.1001/jamapediatrics.2014.1893 25365033
Hansen SN, Schendel DE, Parner ET. Explaining the Increase in the prevalence of autism spectrum disorders. JAMA Pediatr. 2015;169(1):56.25365033 10.1001/jamapediatrics.2014.1893
6. Frye RE Cakir J Rose S Palmer RF Austin C Curtin P Physiological mediators of prenatal environmental influences in autism spectrum disorder BioEssays 2021 43 9 2000307 10.1002/bies.202000307
Frye RE, Cakir J, Rose S, Palmer RF, Austin C, Curtin P. Physiological mediators of prenatal environmental influences in autism spectrum disorder. BioEssays. 2021;43(9):2000307.10.1002/bies.202000307
7. Tong L Kalish BT The impact of maternal obesity on childhood neurodevelopment J Perinatol 2021 41 5 928 939 10.1038/s41372-020-00871-0 33249428
Tong L, Kalish BT. The impact of maternal obesity on childhood neurodevelopment. J Perinatol. 2021;41(5):928–39.33249428 10.1038/s41372-020-00871-0
8. Tioleco N Silberman AE Stratigos K Banerjee-Basu S Spann MN Whitaker AH Prenatal maternal infection and risk for autism in offspring: a meta-analysis Autism Res 2021 14 6 1296 1316 10.1002/aur.2499 33720503
Tioleco N, Silberman AE, Stratigos K, Banerjee-Basu S, Spann MN, Whitaker AH, et al. Prenatal maternal infection and risk for autism in offspring: a meta-analysis. Autism Res. 2021;14(6):1296–316.33720503 10.1002/aur.2499
9. Rowland J Wilson CA The association between gestational diabetes and ASD and ADHD: a systematic review and meta-analysis Sci Rep. 2021 11 1 5136 10.1038/s41598-021-84573-3 33664319
Rowland J, Wilson CA. The association between gestational diabetes and ASD and ADHD: a systematic review and meta-analysis. Sci Rep. 2021;11(1):5136.33664319 10.1038/s41598-021-84573-3
10. Ponsonby A-L Symeonides C Saffery R Mueller JF O’Hely M Sly PD Prenatal phthalate exposure, oxidative stress-related genetic vulnerability and early life neurodevelopment: a birth cohort study Neurotoxicology 2020 80 20 28 10.1016/j.neuro.2020.05.006 32479765
Ponsonby A-L, Symeonides C, Saffery R, Mueller JF, O’Hely M, Sly PD, et al. Prenatal phthalate exposure, oxidative stress-related genetic vulnerability and early life neurodevelopment: a birth cohort study. Neurotoxicology. 2020;80:20–8.32479765 10.1016/j.neuro.2020.05.006
11. Hagberg KW Robijn AL Jick SS Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring Clin Epidemiol 2018 10 1599 1612 10.2147/CLEP.S180618 30464639
Hagberg KW, Robijn AL, Jick SS. Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring. Clin Epidemiol. 2018;10:1599–612.30464639 10.2147/CLEP.S180618
12. Hamad AF Alessi-Severini S Mahmud SM Brownell M Kuo IF Prenatal antibiotics exposure and the risk of autism spectrum disorders: A population-based cohort study PLoS One 2019 14 8 e0221921 10.1371/journal.pone.0221921 31465485
Hamad AF, Alessi-Severini S, Mahmud SM, Brownell M, Kuo IF. Prenatal antibiotics exposure and the risk of autism spectrum disorders: A population-based cohort study. PLoS One. 2019;14(8):e0221921.31465485 10.1371/journal.pone.0221921
13. Chaste P Leboyer M Autism risk factors: genes, environment, and gene-environment interactions Dialogues Clin Neurosci 2012 14 3 281 292 10.31887/DCNS.2012.14.3/pchaste 23226953
Chaste P, Leboyer M. Autism risk factors: genes, environment, and gene-environment interactions. Dialogues Clin Neurosci. 2012;14(3):281–92.23226953 10.31887/DCNS.2012.14.3/pchaste
14. Qiu S Qiu Y Li Y Cong X Genetics of autism spectrum disorder: an umbrella review of systematic reviews and meta-analyses Transl Psychiatry. 2022 12 1 249 10.1038/s41398-022-02009-6 35705542
Qiu S, Qiu Y, Li Y, Cong X. Genetics of autism spectrum disorder: an umbrella review of systematic reviews and meta-analyses. Transl Psychiatry. 2022;12(1):249.35705542 10.1038/s41398-022-02009-6
15. Careaga M Murai T Bauman MD Maternal immune activation and autism spectrum disorder: from rodents to nonhuman and human primates Biol Psychiatry 2017 81 5 391 401 10.1016/j.biopsych.2016.10.020 28137374
Careaga M, Murai T, Bauman MD. Maternal immune activation and autism spectrum disorder: from rodents to nonhuman and human primates. Biol Psychiatry. 2017;81(5):391–401.28137374 10.1016/j.biopsych.2016.10.020
16. Frye RE Cakir J Rose S Palmer RF Austin C Curtin P Mitochondria may mediate prenatal environmental influences in autism spectrum disorder J Pers Med 2021 11 3 218 10.3390/jpm11030218 33803789
Frye RE, Cakir J, Rose S, Palmer RF, Austin C, Curtin P, et al. Mitochondria may mediate prenatal environmental influences in autism spectrum disorder. J Pers Med. 2021;11(3):218.33803789 10.3390/jpm11030218
17. Mandic-Maravic V Mitkovic-Voncina M Pljesa-Ercegovac M Savic-Radojevic A Djordjevic M Pekmezovic T Autism spectrum disorders and perinatal complications—Is oxidative stress the connection? Front Psychiatry. 2019 10 675 10.3389/fpsyt.2019.00675 31681027
Mandic-Maravic V, Mitkovic-Voncina M, Pljesa-Ercegovac M, Savic-Radojevic A, Djordjevic M, Pekmezovic T, et al. Autism spectrum disorders and perinatal complications—Is oxidative stress the connection? Front Psychiatry. 2019;10:675.31681027 10.3389/fpsyt.2019.00675
18. Hsiao EY McBride SW Hsien S Sharon G Hyde ER McCue T Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders Cell 2013 155 7 1451 1463 10.1016/j.cell.2013.11.024 24315484
Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013;155(7):1451–63.24315484 10.1016/j.cell.2013.11.024
19. Worsham W Dalton S Bilder DA The prenatal hormone milieu in autism spectrum disorder Front Psychiatry. 2021 12 655438 10.3389/fpsyt.2021.655438 34276434
Worsham W, Dalton S, Bilder DA. The prenatal hormone milieu in autism spectrum disorder. Front Psychiatry. 2021;12:655438.34276434 10.3389/fpsyt.2021.655438
20. Ornoy A Weinstein-Fudim L Ergaz Z Prenatal factors associated with autism spectrum disorder (ASD) Reprod Toxicol 2015 56 155 169 10.1016/j.reprotox.2015.05.007 26021712
Ornoy A, Weinstein-Fudim L, Ergaz Z. Prenatal factors associated with autism spectrum disorder (ASD). Reprod Toxicol. 2015;56:155–69.26021712 10.1016/j.reprotox.2015.05.007
21. Tordjman S Somogyi E Coulon N Kermarrec S Cohen D Bronsard G Gene× Environment interactions in autism spectrum disorders: role of epigenetic mechanisms Front Psych 2014 5 53
Tordjman S, Somogyi E, Coulon N, Kermarrec S, Cohen D, Bronsard G, et al. Gene× Environment interactions in autism spectrum disorders: role of epigenetic mechanisms. Front Psych. 2014;5:53.
22. Schaaf CP Betancur C Yuen RKC Parr JR Skuse DH Gallagher L A framework for an evidence-based gene list relevant to autism spectrum disorder Nat Rev Genet 2020 21 6 367 376 10.1038/s41576-020-0231-2 32317787
Schaaf CP, Betancur C, Yuen RKC, Parr JR, Skuse DH, Gallagher L, et al. A framework for an evidence-based gene list relevant to autism spectrum disorder. Nat Rev Genet. 2020;21(6):367–76.32317787 10.1038/s41576-020-0231-2
23. Rosenberg RE Law JK Yenokyan G McGready J Kaufmann WE Law PA Characteristics and concordance of autism spectrum disorders among 277 twin pairs Arch Pediatr Adolesc Med 2009 163 10 907 10.1001/archpediatrics.2009.98 19805709
Rosenberg RE, Law JK, Yenokyan G, McGready J, Kaufmann WE, Law PA. Characteristics and concordance of autism spectrum disorders among 277 twin pairs. Arch Pediatr Adolesc Med. 2009;163(10):907.19805709 10.1001/archpediatrics.2009.98
24. Hansen SN Schendel DE Francis RW Windham GC Bresnahan M Levine SZ Recurrence risk of autism in siblings and cousins: a multinational, population-based study J Am Acad Child Adolesc Psychiatry 2019 58 9 866 875 10.1016/j.jaac.2018.11.017 30851399
Hansen SN, Schendel DE, Francis RW, Windham GC, Bresnahan M, Levine SZ, et al. Recurrence risk of autism in siblings and cousins: a multinational, population-based study. J Am Acad Child Adolesc Psychiatry. 2019;58(9):866–75.30851399 10.1016/j.jaac.2018.11.017
25. Bailey A Le Couteur A Gottesman I Bolton P Simonoff E Yuzda E Autism as a strongly genetic disorder: evidence from a British twin study Psychol Med 1995 25 1 63 77 10.1017/S0033291700028099 7792363
Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med. 1995;25(1):63–77.7792363 10.1017/S0033291700028099
26. Sebat J Lakshmi B Malhotra D Troge J Lese-Martin C Walsh T Strong association of de novo copy number mutations with autism Science 2007 316 5823 445 449 10.1126/science.1138659 17363630
Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, et al. Strong association of de novo copy number mutations with autism. Science. 2007;316(5823):445–9.17363630 10.1126/science.1138659
27. Quesnel-Vallières M Weatheritt RJ Cordes SP Blencowe BJ Autism spectrum disorder: insights into convergent mechanisms from transcriptomics Nat Rev Genet 2019 20 1 51 63 10.1038/s41576-018-0066-2 30390048
Quesnel-Vallières M, Weatheritt RJ, Cordes SP, Blencowe BJ. Autism spectrum disorder: insights into convergent mechanisms from transcriptomics. Nat Rev Genet. 2019;20(1):51–63.30390048 10.1038/s41576-018-0066-2
28. Goin-Kochel RP Abbacchi A Constantino JN Autism Genetic Resource Exchange C Lack of evidence for increased genetic loading for autism among families of affected females Autism. 2007 11 3 279 86 10.1177/1362361307076857 17478580
Goin-Kochel RP, Abbacchi A, Constantino JN, Autism Genetic Resource Exchange C. Lack of evidence for increased genetic loading for autism among families of affected females. Autism. 2007;11(3):279–86.17478580 10.1177/1362361307076857
29. Szatmari P Liu XQ Goldberg J Zwaigenbaum L Paterson AD Woodbury-Smith M Sex differences in repetitive stereotyped behaviors in autism: implications for genetic liability Am J Med Genet B Neuropsychiatr Genet 2012 159 1 5 12 10.1002/ajmg.b.31238
Szatmari P, Liu XQ, Goldberg J, Zwaigenbaum L, Paterson AD, Woodbury-Smith M, et al. Sex differences in repetitive stereotyped behaviors in autism: implications for genetic liability. Am J Med Genet B Neuropsychiatr Genet. 2012;159(1):5–12.10.1002/ajmg.b.31238
30. Baron-Cohen S Lombardo MV Auyeung B Ashwin E Chakrabarti B Knickmeyer R Why are autism spectrum conditions more prevalent in males? PLoS Biol 2011 9 6 e1001081 10.1371/journal.pbio.1001081 21695109
Baron-Cohen S, Lombardo MV, Auyeung B, Ashwin E, Chakrabarti B, Knickmeyer R. Why are autism spectrum conditions more prevalent in males? PLoS Biol. 2011;9(6):e1001081.21695109 10.1371/journal.pbio.1001081
31. Napolitano A Schiavi S La Rosa P Rossi-Espagnet MC Petrillo S Bottino F Sex differences in autism spectrum disorder: diagnostic, neurobiological, and behavioral features Front Psychiatry 2022 13 889636 10.3389/fpsyt.2022.889636 35633791
Napolitano A, Schiavi S, La Rosa P, Rossi-Espagnet MC, Petrillo S, Bottino F, et al. Sex differences in autism spectrum disorder: diagnostic, neurobiological, and behavioral features. Front Psychiatry. 2022;13:889636.35633791 10.3389/fpsyt.2022.889636
32. Cheroni C Caporale N Testa G Autism spectrum disorder at the crossroad between genes and environment: contributions, convergences, and interactions in ASD developmental pathophysiology Mol Autism. 2020 11 1 69 10.1186/s13229-020-00370-1 32912338
Cheroni C, Caporale N, Testa G. Autism spectrum disorder at the crossroad between genes and environment: contributions, convergences, and interactions in ASD developmental pathophysiology. Mol Autism. 2020;11(1):69.32912338 10.1186/s13229-020-00370-1
33. Harris JC The origin and natural history of autism spectrum disorders Nat Neurosci 2016 19 11 1390 1391 10.1038/nn.4427 27786188
Harris JC. The origin and natural history of autism spectrum disorders. Nat Neurosci. 2016;19(11):1390–1.27786188 10.1038/nn.4427
34. Chess S Autism in children with congenital rubella J Autism Child Schizophr 1971 1 1 33 47 10.1007/BF01537741 5172438
Chess S. Autism in children with congenital rubella. J Autism Child Schizophr. 1971;1(1):33–47.5172438 10.1007/BF01537741
35. Hutton J Does rubella cause autism: a 2015 reappraisal? Front Hum Neurosci 2016 10 25 10.3389/fnhum.2016.00025 26869906
Hutton J. Does rubella cause autism: a 2015 reappraisal? Front Hum Neurosci. 2016;10:25.26869906 10.3389/fnhum.2016.00025
36. Yamashita Y Fujimoto C Nakajima E Isagai T Matsuishi T Possible association between congenital cytomegalovirus infection and autistic disorder J Autism Dev Disord 2003 33 4 455 459 10.1023/A:1025023131029 12959425
Yamashita Y, Fujimoto C, Nakajima E, Isagai T, Matsuishi T. Possible association between congenital cytomegalovirus infection and autistic disorder. J Autism Dev Disord. 2003;33(4):455–9.12959425 10.1023/A:1025023131029
37. Jiang H-Y Xu L-L Shao L Xia R-M Yu Z-H Ling Z-X Maternal infection during pregnancy and risk of autism spectrum disorders: a systematic review and meta-analysis Brain Behav Immun 2016 58 165 172 10.1016/j.bbi.2016.06.005 27287966
Jiang H-Y, Xu L-L, Shao L, Xia R-M, Yu Z-H, Ling Z-X, et al. Maternal infection during pregnancy and risk of autism spectrum disorders: a systematic review and meta-analysis. Brain Behav Immun. 2016;58:165–72.27287966 10.1016/j.bbi.2016.06.005
38. Yin H Wang Z Liu J Li Y Liu L Huang P Dysregulation of immune and metabolism pathways in maternal immune activation induces an increased risk of autism spectrum disorders Life Sci 2023 324 121734 10.1016/j.lfs.2023.121734 37105442
Yin H, Wang Z, Liu J, Li Y, Liu L, Huang P, et al. Dysregulation of immune and metabolism pathways in maternal immune activation induces an increased risk of autism spectrum disorders. Life Sci. 2023;324:121734.37105442 10.1016/j.lfs.2023.121734
39. Atladóttir HÓ Thorsen P Østergaard L Schendel DE Lemcke S Abdallah M Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders J Autism Dev Disord 2010 40 12 1423 1430 10.1007/s10803-010-1006-y 20414802
Atladóttir HÓ, Thorsen P, Østergaard L, Schendel DE, Lemcke S, Abdallah M, et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord. 2010;40(12):1423–30.20414802 10.1007/s10803-010-1006-y
40. Atladottir HO Henriksen TB Schendel DE Parner ET Autism after infection, febrile episodes, and antibiotic use during pregnancy: an exploratory study Pediatrics 2012 130 6 e1447 e1454 10.1542/peds.2012-1107 23147969
Atladottir HO, Henriksen TB, Schendel DE, Parner ET. Autism after infection, febrile episodes, and antibiotic use during pregnancy: an exploratory study. Pediatrics. 2012;130(6):e1447–54.23147969 10.1542/peds.2012-1107
41. Zerbo O Iosif A-M Walker C Ozonoff S Hansen RL Hertz-Picciotto I Is Maternal Influenza or fever during pregnancy associated with autism or developmental delays? results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) Study J Autism Dev Disord 2013 43 1 25 33 10.1007/s10803-012-1540-x 22562209
Zerbo O, Iosif A-M, Walker C, Ozonoff S, Hansen RL, Hertz-Picciotto I. Is Maternal Influenza or fever during pregnancy associated with autism or developmental delays? results from the CHARGE (CHildhood Autism Risks from Genetics and Environment) Study. J Autism Dev Disord. 2013;43(1):25–33.22562209 10.1007/s10803-012-1540-x
42. Nudel R Thompson WK Børglum AD Hougaard DM Mortensen PB Werge T Maternal pregnancy-related infections and autism spectrum disorder—the genetic perspective Transl Psychiatry 2022 12 1 334 10.1038/s41398-022-02068-9 35974006
Nudel R, Thompson WK, Børglum AD, Hougaard DM, Mortensen PB, Werge T, et al. Maternal pregnancy-related infections and autism spectrum disorder—the genetic perspective. Transl Psychiatry. 2022;12(1):334.35974006 10.1038/s41398-022-02068-9
43. Girchenko P Lahti-Pulkkinen M Heinonen K Reynolds RM Laivuori H Lipsanen J Persistently high levels of maternal antenatal inflammation are associated with and mediate the effect of prenatal environmental adversities on neurodevelopmental delay in the offspring Biol Psychiat 2020 87 10 898 907 10.1016/j.biopsych.2019.12.004 31987493
Girchenko P, Lahti-Pulkkinen M, Heinonen K, Reynolds RM, Laivuori H, Lipsanen J, et al. Persistently high levels of maternal antenatal inflammation are associated with and mediate the effect of prenatal environmental adversities on neurodevelopmental delay in the offspring. Biol Psychiat. 2020;87(10):898–907.31987493 10.1016/j.biopsych.2019.12.004
44. Patel S Dale RC Rose D Heath B Nordahl CW Rogers S Maternal immune conditions are increased in males with autism spectrum disorders and are associated with behavioural and emotional but not cognitive co-morbidity Transl Psychiatry. 2020 10 1 286 10.1038/s41398-020-00976-2 32796821
Patel S, Dale RC, Rose D, Heath B, Nordahl CW, Rogers S, et al. Maternal immune conditions are increased in males with autism spectrum disorders and are associated with behavioural and emotional but not cognitive co-morbidity. Transl Psychiatry. 2020;10(1):286.32796821 10.1038/s41398-020-00976-2
45. Rudolph MD Graham AM Feczko E Miranda-Dominguez O Rasmussen JM Nardos R Maternal IL-6 during pregnancy can be estimated from newborn brain connectivity and predicts future working memory in offspring Nat Neurosci 2018 21 5 765 772 10.1038/s41593-018-0128-y 29632361
Rudolph MD, Graham AM, Feczko E, Miranda-Dominguez O, Rasmussen JM, Nardos R, et al. Maternal IL-6 during pregnancy can be estimated from newborn brain connectivity and predicts future working memory in offspring. Nat Neurosci. 2018;21(5):765–72.29632361 10.1038/s41593-018-0128-y
46. Tartaglione AM Villani A Ajmone-Cat MA Minghetti L Ricceri L Pazienza V Maternal immune activation induces autism-like changes in behavior, neuroinflammatory profile and gut microbiota in mouse offspring of both sexes Transl Psychiatry. 2022 12 1 384 10.1038/s41398-022-02149-9 36104346
Tartaglione AM, Villani A, Ajmone-Cat MA, Minghetti L, Ricceri L, Pazienza V, et al. Maternal immune activation induces autism-like changes in behavior, neuroinflammatory profile and gut microbiota in mouse offspring of both sexes. Transl Psychiatry. 2022;12(1):384.36104346 10.1038/s41398-022-02149-9
47. Bokobza C Van Steenwinckel J Mani S Mezger V Fleiss B Gressens P Neuroinflammation in preterm babies and autism spectrum disorders Pediatr Res 2019 85 2 155 165 10.1038/s41390-018-0208-4 30446768
Bokobza C, Van Steenwinckel J, Mani S, Mezger V, Fleiss B, Gressens P. Neuroinflammation in preterm babies and autism spectrum disorders. Pediatr Res. 2019;85(2):155–65.30446768 10.1038/s41390-018-0208-4
48. Smith SEP Li J Garbett K Mirnics K Patterson PH Maternal immune activation alters fetal brain development through interleukin-6 J Neurosci 2007 27 40 10695 10702 10.1523/JNEUROSCI.2178-07.2007 17913903
Smith SEP, Li J, Garbett K, Mirnics K, Patterson PH. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci. 2007;27(40):10695–702.17913903 10.1523/JNEUROSCI.2178-07.2007
49. Wu W-L Hsiao EY Yan Z Mazmanian SK Patterson PH The placental interleukin-6 signaling controls fetal brain development and behavior Brain Behav Immun 2017 62 11 23 10.1016/j.bbi.2016.11.007 27838335
Wu W-L, Hsiao EY, Yan Z, Mazmanian SK, Patterson PH. The placental interleukin-6 signaling controls fetal brain development and behavior. Brain Behav Immun. 2017;62:11–23.27838335 10.1016/j.bbi.2016.11.007
50. Lim AI McFadden T Link VM Han S-J Karlsson R-M Stacy A Prenatal maternal infection promotes tissue-specific immunity and inflammation in offspring Science. 2021 373 6558 eabf3002 10.1126/science.abf3002 34446580
Lim AI, McFadden T, Link VM, Han S-J, Karlsson R-M, Stacy A, et al. Prenatal maternal infection promotes tissue-specific immunity and inflammation in offspring. Science. 2021;373(6558):eabf3002.34446580 10.1126/science.abf3002
51. Koga K Mor G Toll-like receptors at the maternal–fetal interface in normal pregnancy and pregnancy disorders Am J Reprod Immunol 2010 63 6 587 600 10.1111/j.1600-0897.2010.00848.x 20367625
Koga K, Mor G. Toll-like receptors at the maternal–fetal interface in normal pregnancy and pregnancy disorders. Am J Reprod Immunol. 2010;63(6):587–600.20367625 10.1111/j.1600-0897.2010.00848.x
52. Choi GB Yim YS Wong H Kim S Kim H Kim SV The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring Science 2016 351 6276 933 939 10.1126/science.aad0314 26822608
Choi GB, Yim YS, Wong H, Kim S, Kim H, Kim SV, et al. The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science. 2016;351(6276):933–9.26822608 10.1126/science.aad0314
53. Yasumatsu K Nagao JI Arita-Morioka KI Narita Y Tasaki S Toyoda K Bacterial-induced maternal interleukin-17A pathway promotes autistic-like behaviors in mouse offspring Exp Anim. 2020 69 2 250 60 10.1538/expanim.19-0156 32009087
Yasumatsu K, Nagao JI, Arita-Morioka KI, Narita Y, Tasaki S, Toyoda K, et al. Bacterial-induced maternal interleukin-17A pathway promotes autistic-like behaviors in mouse offspring. Exp Anim. 2020;69(2):250–60.32009087 10.1538/expanim.19-0156
54. Hsiao EY Patterson PH Activation of the maternal immune system induces endocrine changes in the placenta via IL-6 Brain Behav Immun 2011 25 4 604 615 10.1016/j.bbi.2010.12.017 21195166
Hsiao EY, Patterson PH. Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain Behav Immun. 2011;25(4):604–15.21195166 10.1016/j.bbi.2010.12.017
55. Dahlgren J Samuelsson A-M Jansson T Holmäng A Interleukin-6 in the maternal circulation reaches the rat fetus in mid-gestation Pediatr Res 2006 60 2 147 151 10.1203/01.pdr.0000230026.74139.18 16864694
Dahlgren J, Samuelsson A-M, Jansson T, Holmäng A. Interleukin-6 in the maternal circulation reaches the rat fetus in mid-gestation. Pediatr Res. 2006;60(2):147–51.16864694 10.1203/01.pdr.0000230026.74139.18
56. Wei H Zou H Sheikh AM Malik M Dobkin C Brown WT IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation J Neuroinflammation 2011 8 1 52 10.1186/1742-2094-8-52 21595886
Wei H, Zou H, Sheikh AM, Malik M, Dobkin C, Brown WT, et al. IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formation. J Neuroinflammation. 2011;8(1):52.21595886 10.1186/1742-2094-8-52
57. Estes ML McAllister AK Maternal immune activation: Implications for neuropsychiatric disorders Science 2016 353 6301 772 777 10.1126/science.aag3194 27540164
Estes ML, McAllister AK. Maternal immune activation: Implications for neuropsychiatric disorders. Science. 2016;353(6301):772–7.27540164 10.1126/science.aag3194
58. Meyer U Neurodevelopmental resilience and susceptibility to maternal immune activation Trends Neurosci 2019 42 11 793 806 10.1016/j.tins.2019.08.001 31493924
Meyer U. Neurodevelopmental resilience and susceptibility to maternal immune activation. Trends Neurosci. 2019;42(11):793–806.31493924 10.1016/j.tins.2019.08.001
59. Gyllenhammer LE Rasmussen JM Bertele N Halbing A Entringer S Wadhwa PD Maternal inflammation during pregnancy and offspring brain development: the role of mitochondria Biol Psychiatry Cogn Neurosci Neuroimaging 2022 7 5 498 509 34800727
Gyllenhammer LE, Rasmussen JM, Bertele N, Halbing A, Entringer S, Wadhwa PD, et al. Maternal inflammation during pregnancy and offspring brain development: the role of mitochondria. Biol Psychiatry Cogn Neurosci Neuroimaging. 2022;7(5):498–509.34800727
60. Mills EL Kelly B Logan A Costa ASH Varma M Bryant CE Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages Cell 2016 167 2 457 70.e13 10.1016/j.cell.2016.08.064 27667687
Mills EL, Kelly B, Logan A, Costa ASH, Varma M, Bryant CE, et al. Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell. 2016;167(2):457-70.e13.27667687 10.1016/j.cell.2016.08.064
61. Nair S Sobotka KS Joshi P Gressens P Fleiss B Thornton C Lipopolysaccharide-induced alteration of mitochondrial morphology induces a metabolic shift in microglia modulating the inflammatory response in vitro and in vivo Glia 2019 67 6 1047 1061 10.1002/glia.23587 30637805
Nair S, Sobotka KS, Joshi P, Gressens P, Fleiss B, Thornton C, et al. Lipopolysaccharide-induced alteration of mitochondrial morphology induces a metabolic shift in microglia modulating the inflammatory response in vitro and in vivo. Glia. 2019;67(6):1047–61.30637805 10.1002/glia.23587
62. M Wilkins H H Swerdlow R Relationships between mitochondria and neuroinflammation: implications for Alzheimer’s disease Curr Top Med Chem 2016 16 8 849 57 10.2174/1568026615666150827095102 26311426
M Wilkins H, H Swerdlow R. Relationships between mitochondria and neuroinflammation: implications for Alzheimer’s disease. Curr Top Med Chem. 2016;16(8):849–57.26311426 10.2174/1568026615666150827095102
63. Swanepoel T Möller M Harvey BH N-acetyl cysteine reverses bio-behavioural changes induced by prenatal inflammation, adolescent methamphetamine exposure and combined challenges Psychopharmacology 2018 235 1 351 368 10.1007/s00213-017-4776-5 29116368
Swanepoel T, Möller M, Harvey BH. N-acetyl cysteine reverses bio-behavioural changes induced by prenatal inflammation, adolescent methamphetamine exposure and combined challenges. Psychopharmacology. 2018;235(1):351–68.29116368 10.1007/s00213-017-4776-5
64. Anitha A Nakamura K Thanseem I Matsuzaki H Miyachi T Tsujii M Downregulation of the expression of mitochondrial electron transport complex genes in autism brains Brain Pathol 2013 23 3 294 302 10.1111/bpa.12002 23088660
Anitha A, Nakamura K, Thanseem I, Matsuzaki H, Miyachi T, Tsujii M, et al. Downregulation of the expression of mitochondrial electron transport complex genes in autism brains. Brain Pathol. 2013;23(3):294–302.23088660 10.1111/bpa.12002
65. Kato Y Yokokura M Iwabuchi T Murayama C Harada T Goto T Lower availability of mitochondrial complex I in anterior cingulate cortex in autism: a positron emission tomography study Am J Psychiatry 2023 180 4 277 284 10.1176/appi.ajp.22010014 36069020
Kato Y, Yokokura M, Iwabuchi T, Murayama C, Harada T, Goto T, et al. Lower availability of mitochondrial complex I in anterior cingulate cortex in autism: a positron emission tomography study. Am J Psychiatry. 2023;180(4):277–84.36069020 10.1176/appi.ajp.22010014
66. Liong S Miles MA Mohsenipour M Liong F Hill-Yardin EL Selemidis S Influenza A virus infection during pregnancy causes immunological changes in gut-associated lymphoid tissues of offspring mice Am J Physiol Gastrointest Liver Physiol. 2023 325 3 G230 G8 10.1152/ajpgi.00062.2023 37431584
Liong S, Miles MA, Mohsenipour M, Liong F, Hill-Yardin EL, Selemidis S. Influenza A virus infection during pregnancy causes immunological changes in gut-associated lymphoid tissues of offspring mice. Am J Physiol Gastrointest Liver Physiol. 2023;325(3):G230–8.37431584 10.1152/ajpgi.00062.2023
67. Liong S Oseghale O To EE Brassington K Erlich JR Luong R Influenza A virus causes maternal and fetal pathology via innate and adaptive vascular inflammation in mice Proc Natl Acad Sci 2020 117 40 24964 24973 10.1073/pnas.2006905117 32958663
Liong S, Oseghale O, To EE, Brassington K, Erlich JR, Luong R, et al. Influenza A virus causes maternal and fetal pathology via innate and adaptive vascular inflammation in mice. Proc Natl Acad Sci. 2020;117(40):24964–73.32958663 10.1073/pnas.2006905117
68. Li N Yang J Zhang J Liang C Wang Y Chen B Correlation of gut microbiome between ASD children and mothers and potential biomarkers for risk assessment Genomics Proteomics Bioinformatics 2019 17 1 26 38 10.1016/j.gpb.2019.01.002 31026579
Li N, Yang J, Zhang J, Liang C, Wang Y, Chen B, et al. Correlation of gut microbiome between ASD children and mothers and potential biomarkers for risk assessment. Genomics Proteomics Bioinformatics. 2019;17(1):26–38.31026579 10.1016/j.gpb.2019.01.002
69. Han VX Patel S Jones HF Nielsen TC Mohammad SS Hofer MJ Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: a systematic review Transl Psychiatry. 2021 11 1 71 10.1038/s41398-021-01198-w 33479207
Han VX, Patel S, Jones HF, Nielsen TC, Mohammad SS, Hofer MJ, et al. Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: a systematic review. Transl Psychiatry. 2021;11(1):71.33479207 10.1038/s41398-021-01198-w
70. Bordeleau M Lacabanne C de Fernández Cossío L Vernoux N Savage JC González-Ibáñez F Microglial and peripheral immune priming is partially sexually dimorphic in adolescent mouse offspring exposed to maternal high-fat diet J Neuroinflamm. 2020 17 1 28 10.1186/s12974-020-01914-1
Bordeleau M, Lacabanne C, de Fernández Cossío L, Vernoux N, Savage JC, González-Ibáñez F, et al. Microglial and peripheral immune priming is partially sexually dimorphic in adolescent mouse offspring exposed to maternal high-fat diet. J Neuroinflamm. 2020;17:1–28.10.1186/s12974-020-01914-1
71. Xavier S Soch A Younesi S Malik S Spencer SJ Sominsky L Maternal diet before and during pregnancy modulates microglial activation and neurogenesis in the postpartum rat brain Brain Behav Immun 2021 98 185 197 10.1016/j.bbi.2021.08.223 34418500
Xavier S, Soch A, Younesi S, Malik S, Spencer SJ, Sominsky L. Maternal diet before and during pregnancy modulates microglial activation and neurogenesis in the postpartum rat brain. Brain Behav Immun. 2021;98:185–97.34418500 10.1016/j.bbi.2021.08.223
72. Bilbo SD Tsang V Enduring consequences of maternal obesity for brain inflammation and behavior of offspring FASEB J 2010 24 6 2104 2115 10.1096/fj.09-144014 20124437
Bilbo SD, Tsang V. Enduring consequences of maternal obesity for brain inflammation and behavior of offspring. FASEB J. 2010;24(6):2104–15.20124437 10.1096/fj.09-144014
73. Piazza FV Segabinazi E De Meireles ALF Mega F Spindler CDF Augustin OA Severe uncontrolled maternal hyperglycemia induces microsomia and neurodevelopment delay accompanied by apoptosis, cellular survival, and neuroinflammatory deregulation in rat offspring hippocampus Cell Mol Neurobiol 2019 39 3 401 414 10.1007/s10571-019-00658-8 30739252
Piazza FV, Segabinazi E, De Meireles ALF, Mega F, Spindler CDF, Augustin OA, et al. Severe uncontrolled maternal hyperglycemia induces microsomia and neurodevelopment delay accompanied by apoptosis, cellular survival, and neuroinflammatory deregulation in rat offspring hippocampus. Cell Mol Neurobiol. 2019;39(3):401–14.30739252 10.1007/s10571-019-00658-8
74. Muller CL Anacker AMJ Veenstra-Vanderweele J The serotonin system in autism spectrum disorder: from biomarker to animal models Neuroscience 2016 321 24 41 10.1016/j.neuroscience.2015.11.010 26577932
Muller CL, Anacker AMJ, Veenstra-Vanderweele J. The serotonin system in autism spectrum disorder: from biomarker to animal models. Neuroscience. 2016;321:24–41.26577932 10.1016/j.neuroscience.2015.11.010
75. Kim S Kim H Yim YS Ha S Atarashi K Tan TG Maternal gut bacteria promote neurodevelopmental abnormalities in mouse offspring Nature 2017 549 7673 528 532 10.1038/nature23910 28902840
Kim S, Kim H, Yim YS, Ha S, Atarashi K, Tan TG, et al. Maternal gut bacteria promote neurodevelopmental abnormalities in mouse offspring. Nature. 2017;549(7673):528–32.28902840 10.1038/nature23910
76. Bolton JL Marinero S Hassanzadeh T Natesan D Le D Belliveau C Gestational exposure to air pollution alters cortical volume, microglial morphology, and microglia-neuron interactions in a sex-specific manner Front Synaptic Neurosci. 2017 9 10 10.3389/fnsyn.2017.00010 28620294
Bolton JL, Marinero S, Hassanzadeh T, Natesan D, Le D, Belliveau C, et al. Gestational exposure to air pollution alters cortical volume, microglial morphology, and microglia-neuron interactions in a sex-specific manner. Front Synaptic Neurosci. 2017;9:10.28620294 10.3389/fnsyn.2017.00010
77. Xiao L Feng J Zhang W Pan J Wang M Zhang C Autism-like behavior of murine offspring induced by prenatal exposure to progestin is associated with gastrointestinal dysfunction due to claudin-1 suppression Febs j 2023 290 13 3369 3382 10.1111/febs.16761 36855792
Xiao L, Feng J, Zhang W, Pan J, Wang M, Zhang C, et al. Autism-like behavior of murine offspring induced by prenatal exposure to progestin is associated with gastrointestinal dysfunction due to claudin-1 suppression. Febs j. 2023;290(13):3369–82.36855792 10.1111/febs.16761
78. de Oliveira MR Fluoxetine and the mitochondria: a review of the toxicological aspects Toxicol Lett 2016 258 185 191 10.1016/j.toxlet.2016.07.001 27392437
de Oliveira MR. Fluoxetine and the mitochondria: a review of the toxicological aspects. Toxicol Lett. 2016;258:185–91.27392437 10.1016/j.toxlet.2016.07.001
79. Emmerzaal TL Nijkamp G Veldic M Rahman S Andreazza AC Morava E Effect of neuropsychiatric medications on mitochondrial function: for better or for worse Neurosci Biobehav Rev 2021 127 555 571 10.1016/j.neubiorev.2021.05.001 34000348
Emmerzaal TL, Nijkamp G, Veldic M, Rahman S, Andreazza AC, Morava E, et al. Effect of neuropsychiatric medications on mitochondrial function: for better or for worse. Neurosci Biobehav Rev. 2021;127:555–71.34000348 10.1016/j.neubiorev.2021.05.001
80. Houttu N Mokkala K Laitinen K Overweight and obesity status in pregnant women are related to intestinal microbiota and serum metabolic and inflammatory profiles Clin Nutr. 2018 37 6 Pt A 1955 66 10.1016/j.clnu.2017.12.013 29338886
Houttu N, Mokkala K, Laitinen K. Overweight and obesity status in pregnant women are related to intestinal microbiota and serum metabolic and inflammatory profiles. Clin Nutr. 2018;37(6 Pt A):1955–66.29338886 10.1016/j.clnu.2017.12.013
81. Kuang Y-S Lu J-H Li S-H Li J-H Yuan M-Y He J-R Connections between the human gut microbiome and gestational diabetes mellitus GigaScience. 2017 6 8 1 12 10.1093/gigascience/gix058 29046044
Kuang Y-S, Lu J-H, Li S-H, Li J-H, Yuan M-Y, He J-R, et al. Connections between the human gut microbiome and gestational diabetes mellitus. GigaScience. 2017;6(8):1–12.29046044 10.1093/gigascience/gix058
82. Pronovost GN Yu KB Elena J Telang SS Chen AS Vuong HE The maternal microbiome promotes placental development in mice Sci Adv. 2023 9 40 eadk1887 10.1126/sciadv.adk1887 37801498
Pronovost GN, Yu KB, Elena J, Telang SS, Chen AS, Vuong HE, et al. The maternal microbiome promotes placental development in mice. Sci Adv. 2023;9(40):eadk1887.37801498 10.1126/sciadv.adk1887
83. Kratsman N Getselter D Elliott E Sodium butyrate attenuates social behavior deficits and modifies the transcription of inhibitory/excitatory genes in the frontal cortex of an autism model Neuropharmacology 2016 102 136 145 10.1016/j.neuropharm.2015.11.003 26577018
Kratsman N, Getselter D, Elliott E. Sodium butyrate attenuates social behavior deficits and modifies the transcription of inhibitory/excitatory genes in the frontal cortex of an autism model. Neuropharmacology. 2016;102:136–45.26577018 10.1016/j.neuropharm.2015.11.003
84. Koren O Goodrich JK Cullender TC Spor A Laitinen K Backhed HK Host remodeling of the gut microbiome and metabolic changes during pregnancy Cell 2012 150 3 470 480 10.1016/j.cell.2012.07.008 22863002
Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, Backhed HK, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell. 2012;150(3):470–80.22863002 10.1016/j.cell.2012.07.008
85. Nuriel-Ohayon M Neuman H Koren O Microbial changes during pregnancy, birth, and infancy Front Microbiol. 2016 7 1031 10.3389/fmicb.2016.01031 27471494
Nuriel-Ohayon M, Neuman H, Koren O. Microbial changes during pregnancy, birth, and infancy. Front Microbiol. 2016;7:1031.27471494 10.3389/fmicb.2016.01031
86. Reigstad CS Salmonson CE Rainey JF III Szurszewski JH Linden DR Sonnenburg JL Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells FASEB J 2015 29 4 1395 10.1096/fj.14-259598 25550456
Reigstad CS, Salmonson CE, Rainey JF III, Szurszewski JH, Linden DR, Sonnenburg JL, et al. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J. 2015;29(4):1395.25550456 10.1096/fj.14-259598
87. Rodnyy AY, Kondaurova EM, Tsybko AS, Popova NK, Kudlay DA, Naumenko VS. The brain serotonin system in autism. Rev Neurosci. 2023;35(1):1–20. 10.1515/revneuro-2023-0055.
88. Chen CM Chou HC Yang YCSH Maternal antibiotic treatment disrupts the intestinal microbiota and intestinal development in neonatal mice Front Microbiol. 2021 12 684233 10.3389/fmicb.2021.684233 34177871
Chen CM, Chou HC, Yang YCSH. Maternal antibiotic treatment disrupts the intestinal microbiota and intestinal development in neonatal mice. Front Microbiol. 2021;12:684233.34177871 10.3389/fmicb.2021.684233
89. Agrawal R Agrawal A Jacson MJ Maternal obesity and autism spectrum disorders in offspring Indian J Child Health 2022 9 10 178 182 10.32677/ijch.v9i10.3690
Agrawal R, Agrawal A, Jacson MJ. Maternal obesity and autism spectrum disorders in offspring. Indian J Child Health. 2022;9(10):178–82.10.32677/ijch.v9i10.3690
90. Qiu C Williams MA Vadachkoria S Frederick IO Luthy DA Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitus Obstet Gynecol 2004 103 3 519 525 10.1097/01.AOG.0000113621.53602.7a 14990416
Qiu C, Williams MA, Vadachkoria S, Frederick IO, Luthy DA. Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitus. Obstet Gynecol. 2004;103(3):519–25.14990416 10.1097/01.AOG.0000113621.53602.7a
91. Braun JM Kalkbrenner AE Just AC Yolton K Calafat AM Sjödin A Gestational exposure to endocrine-disrupting chemicals and reciprocal social, repetitive, and stereotypic behaviors in 4-and 5-year-old children: the HOME study Environ Health Perspect 2014 122 5 513 520 10.1289/ehp.1307261 24622245
Braun JM, Kalkbrenner AE, Just AC, Yolton K, Calafat AM, Sjödin A, et al. Gestational exposure to endocrine-disrupting chemicals and reciprocal social, repetitive, and stereotypic behaviors in 4-and 5-year-old children: the HOME study. Environ Health Perspect. 2014;122(5):513–20.24622245 10.1289/ehp.1307261
92. Symeonides C Vacy K Thomson S Tanner S Chua HK Dixit S Male autism spectrum disorder is linked to brain aromatase disruption by prenatal BPA in multimodal investigations and 10HDA ameliorates the related mouse phenotype Nat Commun 2024 15 1 6367 10.1038/s41467-024-48897-8 39112449
Symeonides C, Vacy K, Thomson S, Tanner S, Chua HK, Dixit S, et al. Male autism spectrum disorder is linked to brain aromatase disruption by prenatal BPA in multimodal investigations and 10HDA ameliorates the related mouse phenotype. Nat Commun. 2024;15(1):6367.39112449 10.1038/s41467-024-48897-8
93. Bhat RS Alonazi M Al-Daihan S El-Ansary A Prenatal SSRI exposure increases the risk of autism in rodents via aggravated oxidative stress and neurochemical changes in the brain Metabolites 2023 13 2 310 10.3390/metabo13020310 36837929
Bhat RS, Alonazi M, Al-Daihan S, El-Ansary A. Prenatal SSRI exposure increases the risk of autism in rodents via aggravated oxidative stress and neurochemical changes in the brain. Metabolites. 2023;13(2):310.36837929 10.3390/metabo13020310
94. Thomson S Drummond K O'Hely M Symeonides C Chandran C Mansell T Increased maternal non-oxidative energy metabolism mediates association between prenatal di-(2-ethylhexyl) phthalate (DEHP) exposure and offspring autism spectrum disorder symptoms in early life: A birth cohort study Environ Int 2023 171 107678 10.1016/j.envint.2022.107678 36516674
Thomson S, Drummond K, O’Hely M, Symeonides C, Chandran C, Mansell T, et al. Increased maternal non-oxidative energy metabolism mediates association between prenatal di-(2-ethylhexyl) phthalate (DEHP) exposure and offspring autism spectrum disorder symptoms in early life: A birth cohort study. Environ Int. 2023;171:107678.36516674 10.1016/j.envint.2022.107678
95. Tanner S Thomson S Drummond K O’Hely M Symeonides C Mansell T A pathway-based genetic score for oxidative stress: an indicator of host vulnerability to phthalate-associated adverse neurodevelopment Antioxidants 2022 11 4 659 10.3390/antiox11040659 35453345
Tanner S, Thomson S, Drummond K, O’Hely M, Symeonides C, Mansell T, et al. A pathway-based genetic score for oxidative stress: an indicator of host vulnerability to phthalate-associated adverse neurodevelopment. Antioxidants. 2022;11(4):659.35453345 10.3390/antiox11040659
96. Xu G Jing J Bowers K Liu B Bao W Maternal diabetes and the risk of autism spectrum disorders in the offspring: a systematic review and meta-analysis J Autism Dev Disord 2014 44 4 766 775 10.1007/s10803-013-1928-2 24057131
Xu G, Jing J, Bowers K, Liu B, Bao W. Maternal diabetes and the risk of autism spectrum disorders in the offspring: a systematic review and meta-analysis. J Autism Dev Disord. 2014;44(4):766–75.24057131 10.1007/s10803-013-1928-2
97. Xiang AH Wang X Martinez MP Walthall JC Curry ES Page K Association of maternal diabetes with autism in offspring JAMA 2015 313 14 1425 1434 10.1001/jama.2015.2707 25871668
Xiang AH, Wang X, Martinez MP, Walthall JC, Curry ES, Page K, et al. Association of maternal diabetes with autism in offspring. JAMA. 2015;313(14):1425–34.25871668 10.1001/jama.2015.2707
98. Kong L Chen X Gissler M Lavebratt C Relationship of prenatal maternal obesity and diabetes to offspring neurodevelopmental and psychiatric disorders: a narrative review Int J Obes 2020 44 10 1981 2000 10.1038/s41366-020-0609-4
Kong L, Chen X, Gissler M, Lavebratt C. Relationship of prenatal maternal obesity and diabetes to offspring neurodevelopmental and psychiatric disorders: a narrative review. Int J Obes. 2020;44(10):1981–2000.10.1038/s41366-020-0609-4
99. Ye W Luo C Huang J Li C Liu Z Liu F Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis BMJ. 2022 377 e067946 10.1136/bmj-2021-067946 35613728
Ye W, Luo C, Huang J, Li C, Liu Z, Liu F. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis. BMJ. 2022;377:e067946.35613728 10.1136/bmj-2021-067946
100. Khambule L, George JA. The role of inflammation in the development of GDM and the use of markers of inflammation in GDM screening. In: Guest, P. (eds) reviews on biomarker studies of metabolic and metabolism-related disorders. Advances in experimental medicine and biology, vol 1134. Cham: Springer; 2019. 10.1007/978-3-030-12668-1_12.
101. Sotgiu S Manca S Gagliano A Minutolo A Melis MC Pisuttu G Immune regulation of neurodevelopment at the mother–foetus interface: the case of autism Clin Transl Immunol 2020 9 11 e1211 10.1002/cti2.1211
Sotgiu S, Manca S, Gagliano A, Minutolo A, Melis MC, Pisuttu G, et al. Immune regulation of neurodevelopment at the mother–foetus interface: the case of autism. Clin Transl Immunol. 2020;9(11):e1211.10.1002/cti2.1211
102. Berenbaum SA Beltz AM How early hormones shape gender development Curr Opin Behav Sci 2016 7 53 60 10.1016/j.cobeha.2015.11.011 26688827
Berenbaum SA, Beltz AM. How early hormones shape gender development. Curr Opin Behav Sci. 2016;7:53–60.26688827 10.1016/j.cobeha.2015.11.011
103. McCarthy MM Multifaceted origins of sex differences in the brain Philos Trans R Soc B Biol Sci 2016 371 1688 20150106 10.1098/rstb.2015.0106
McCarthy MM. Multifaceted origins of sex differences in the brain. Philos Trans R Soc B Biol Sci. 2016;371(1688):20150106.10.1098/rstb.2015.0106
104. Behura SK Kelleher AM Spencer TE Evidence for functional interactions between the placenta and brain in pregnant mice FASEB J 2019 33 3 4261 10.1096/fj.201802037R 30521381
Behura SK, Kelleher AM, Spencer TE. Evidence for functional interactions between the placenta and brain in pregnant mice. FASEB J. 2019;33(3):4261.30521381 10.1096/fj.201802037R
105. Bale TL The placenta and neurodevelopment: sex differences in prenatal vulnerability Dialogues Clin Neurosci 2016 18 4 459 464 10.31887/DCNS.2016.18.4/tbale 28179817
Bale TL. The placenta and neurodevelopment: sex differences in prenatal vulnerability. Dialogues Clin Neurosci. 2016;18(4):459–64.28179817 10.31887/DCNS.2016.18.4/tbale
106. Aljumaiah MM Alonazi MA Al-Dbass AM Almnaizel AT Alahmed M Soliman DA Association of maternal diabetes and autism spectrum disorders in offspring: a study in a rodent model of autism J Mol Neurosci 2022 72 2 349 358 10.1007/s12031-021-01912-9 34562183
Aljumaiah MM, Alonazi MA, Al-Dbass AM, Almnaizel AT, Alahmed M, Soliman DA, et al. Association of maternal diabetes and autism spectrum disorders in offspring: a study in a rodent model of autism. J Mol Neurosci. 2022;72(2):349–58.34562183 10.1007/s12031-021-01912-9
107. Harrington RA Lee L-C Crum RM Zimmerman AW Hertz-Picciotto I Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay Pediatrics 2014 133 5 e1241 e1248 10.1542/peds.2013-3406 24733881
Harrington RA, Lee L-C, Crum RM, Zimmerman AW, Hertz-Picciotto I. Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay. Pediatrics. 2014;133(5):e1241–8.24733881 10.1542/peds.2013-3406
108. Sørensen MJ Grønborg TK Christensen J Parner ET Vestergaard M Schendel D Antidepressant exposure in pregnancy and risk of autism spectrum disorders Clin Epidemiol. 2013 5 null 449 59 10.2147/CLEP.S53009 24255601
Sørensen MJ, Grønborg TK, Christensen J, Parner ET, Vestergaard M, Schendel D, et al. Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Clin Epidemiol. 2013;5(null):449–59.24255601 10.2147/CLEP.S53009
109. Malm H Brown AS Gissler M Gyllenberg D Hinkka-Yli-Salomäki S McKeague IW Gestational exposure to selective serotonin reuptake inhibitors and offspring psychiatric disorders: a national register-based study J Am Acad Child Adolesc Psychiatry 2016 55 5 359 366 10.1016/j.jaac.2016.02.013 27126849
Malm H, Brown AS, Gissler M, Gyllenberg D, Hinkka-Yli-Salomäki S, McKeague IW, et al. Gestational exposure to selective serotonin reuptake inhibitors and offspring psychiatric disorders: a national register-based study. J Am Acad Child Adolesc Psychiatry. 2016;55(5):359–66.27126849 10.1016/j.jaac.2016.02.013
110. Kaplan YC Keskin-Arslan E Acar S Sozmen K Prenatal selective serotonin reuptake inhibitor use and the risk of autism spectrum disorder in children: a systematic review and meta-analysis Reprod Toxicol 2016 66 31 43 10.1016/j.reprotox.2016.09.013 27667009
Kaplan YC, Keskin-Arslan E, Acar S, Sozmen K. Prenatal selective serotonin reuptake inhibitor use and the risk of autism spectrum disorder in children: a systematic review and meta-analysis. Reprod Toxicol. 2016;66:31–43.27667009 10.1016/j.reprotox.2016.09.013
111. Mezzacappa A Lasica P-A Gianfagna F Cazas O Hardy P Falissard B Risk for autism spectrum disorders according to period of prenatal antidepressant exposure: a systematic review and meta-analysis JAMA Pediatr 2017 171 6 555 563 10.1001/jamapediatrics.2017.0124 28418571
Mezzacappa A, Lasica P-A, Gianfagna F, Cazas O, Hardy P, Falissard B, et al. Risk for autism spectrum disorders according to period of prenatal antidepressant exposure: a systematic review and meta-analysis. JAMA Pediatr. 2017;171(6):555–63.28418571 10.1001/jamapediatrics.2017.0124
112. Ornoy A Valproic acid in pregnancy: How much are we endangering the embryo and fetus? Reprod Toxicol 2009 28 1 1 10 10.1016/j.reprotox.2009.02.014 19490988
Ornoy A. Valproic acid in pregnancy: How much are we endangering the embryo and fetus? Reprod Toxicol. 2009;28(1):1–10.19490988 10.1016/j.reprotox.2009.02.014
113. Vargesson N Thalidomide-induced teratogenesis: history and mechanisms Birth Defects Res C Embryo Today 2015 105 2 140 156 10.1002/bdrc.21096 26043938
Vargesson N. Thalidomide-induced teratogenesis: history and mechanisms. Birth Defects Res C Embryo Today. 2015;105(2):140–56.26043938 10.1002/bdrc.21096
114. Kobayashi T Matsuyama T Takeuchi M Ito S Autism spectrum disorder and prenatal exposure to selective serotonin reuptake inhibitors: a systematic review and meta-analysis Reprod Toxicol 2016 65 170 178 10.1016/j.reprotox.2016.07.016 27474253
Kobayashi T, Matsuyama T, Takeuchi M, Ito S. Autism spectrum disorder and prenatal exposure to selective serotonin reuptake inhibitors: a systematic review and meta-analysis. Reprod Toxicol. 2016;65:170–8.27474253 10.1016/j.reprotox.2016.07.016
115. Keks N Hope J Keogh S Switching and stopping antidepressants Aust Prescr 2016 39 3 76 27346915
Keks N, Hope J, Keogh S. Switching and stopping antidepressants. Aust Prescr. 2016;39(3):76.27346915
116. Yin W Pulakka A Reichenberg A Kolevzon A Ludvigsson JF Risnes K Association between parental psychiatric disorders and risk of offspring autism spectrum disorder: a Swedish and Finnish population-based cohort study Lancet Regional Health Eur 2024 40 100902 10.1016/j.lanepe.2024.100902
Yin W, Pulakka A, Reichenberg A, Kolevzon A, Ludvigsson JF, Risnes K, et al. Association between parental psychiatric disorders and risk of offspring autism spectrum disorder: a Swedish and Finnish population-based cohort study. Lancet Regional Health Eur. 2024;40:100902.10.1016/j.lanepe.2024.100902
117. Vaswani M Linda FK Ramesh S Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review Prog Neuropsychopharmacol Biol Psychiatry 2003 27 1 85 102 10.1016/S0278-5846(02)00338-X 12551730
Vaswani M, Linda FK, Ramesh S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(1):85–102.12551730 10.1016/S0278-5846(02)00338-X
118. Gershon MD 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract Curr Opin Endocrinol Diabetes Obes 2013 20 1 14 10.1097/MED.0b013e32835bc703 23222853
Gershon MD. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes. 2013;20(1):14.23222853 10.1097/MED.0b013e32835bc703
119. Kim H Toyofuku Y Lynn FC Chak E Uchida T Mizukami H Serotonin regulates pancreatic beta cell mass during pregnancy Nat Med 2010 16 7 804 808 10.1038/nm.2173 20581837
Kim H, Toyofuku Y, Lynn FC, Chak E, Uchida T, Mizukami H, et al. Serotonin regulates pancreatic beta cell mass during pregnancy. Nat Med. 2010;16(7):804–8.20581837 10.1038/nm.2173
120. Bonnin A Goeden N Chen K Wilson ML King J Shih JC A transient placental source of serotonin for the fetal forebrain Nature 2011 472 7343 347 350 10.1038/nature09972 21512572
Bonnin A, Goeden N, Chen K, Wilson ML, King J, Shih JC, et al. A transient placental source of serotonin for the fetal forebrain. Nature. 2011;472(7343):347–50.21512572 10.1038/nature09972
121. Sujan AC Öberg AS Quinn PD D'Onofrio BM Annual Research Review: Maternal antidepressant use during pregnancy and offspring neurodevelopmental problems - a critical review and recommendations for future research J Child Psychol Psychiatry 2019 60 4 356 376 10.1111/jcpp.13004 30515808
Sujan AC, Öberg AS, Quinn PD, D’Onofrio BM. Annual Research Review: Maternal antidepressant use during pregnancy and offspring neurodevelopmental problems - a critical review and recommendations for future research. J Child Psychol Psychiatry. 2019;60(4):356–76.30515808 10.1111/jcpp.13004
122. da LD Barros M Manhaes-de-castro R Alves DT Quevedo OG Toscano AE Bonnin A Long term effects of neonatal exposure to fluoxetine on energy balance: a systematic review of experimental studies Eur J Pharmacol. 2018 833 298 306 10.1016/j.ejphar.2018.06.013 29890156
da LD Barros M, Manhaes-de-castro R, Alves DT, Quevedo OG, Toscano AE, Bonnin A, et al. Long term effects of neonatal exposure to fluoxetine on energy balance: a systematic review of experimental studies. Eur J Pharmacol. 2018;833:298–306.29890156 10.1016/j.ejphar.2018.06.013
123. De Angelis M Piccolo M Vannini L Siragusa S De Giacomo A Serrazzanetti DI Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified PLoS One 2013 8 10 e76993 10.1371/journal.pone.0076993 24130822
De Angelis M, Piccolo M, Vannini L, Siragusa S, De Giacomo A, Serrazzanetti DI, et al. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One. 2013;8(10):e76993.24130822 10.1371/journal.pone.0076993
124. Lee E Cho J Kim KY The association between autism spectrum disorder and pre- and postnatal antibiotic exposure in childhood—A systematic review with meta-analysis Int J Environ Res Public Health 2019 16 20 4042 10.3390/ijerph16204042 31652518
Lee E, Cho J, Kim KY. The association between autism spectrum disorder and pre- and postnatal antibiotic exposure in childhood—A systematic review with meta-analysis. Int J Environ Res Public Health. 2019;16(20):4042.31652518 10.3390/ijerph16204042
125. Wimberley T Agerbo E Pedersen CB Dalsgaard S Horsdal HT Mortensen PB Otitis media, antibiotics, and risk of autism spectrum disorder Autism Res 2018 11 10 1432 1440 10.1002/aur.2015 30284386
Wimberley T, Agerbo E, Pedersen CB, Dalsgaard S, Horsdal HT, Mortensen PB, et al. Otitis media, antibiotics, and risk of autism spectrum disorder. Autism Res. 2018;11(10):1432–40.30284386 10.1002/aur.2015
126. Holingue C Brucato M Ladd-Acosta C Hong X Volk H Mueller NT Interaction between maternal immune activation and antibiotic use during pregnancy and child risk of autism spectrum disorder Autism Res 2020 13 12 2230 2241 10.1002/aur.2411 33067915
Holingue C, Brucato M, Ladd-Acosta C, Hong X, Volk H, Mueller NT, et al. Interaction between maternal immune activation and antibiotic use during pregnancy and child risk of autism spectrum disorder. Autism Res. 2020;13(12):2230–41.33067915 10.1002/aur.2411
127. Moosa A Shu H Sarachana T Hu VW Are endocrine disrupting compounds environmental risk factors for autism spectrum disorder? Horm Behav 2018 101 13 21 10.1016/j.yhbeh.2017.10.003 29042182
Moosa A, Shu H, Sarachana T, Hu VW. Are endocrine disrupting compounds environmental risk factors for autism spectrum disorder? Horm Behav. 2018;101:13–21.29042182 10.1016/j.yhbeh.2017.10.003
128. Haggerty DK Strakovsky RS Talge NM Carignan CC Glazier-Essalmi AN Ingersoll BR Prenatal phthalate exposures and autism spectrum disorder symptoms in low-risk children Neurotoxicol Teratol 2021 83 106947 10.1016/j.ntt.2021.106947 33412243
Haggerty DK, Strakovsky RS, Talge NM, Carignan CC, Glazier-Essalmi AN, Ingersoll BR, et al. Prenatal phthalate exposures and autism spectrum disorder symptoms in low-risk children. Neurotoxicol Teratol. 2021;83:106947.33412243 10.1016/j.ntt.2021.106947
129. Oulhote Y Lanphear B Braun JM Webster GM Arbuckle TE Etzel T Gestational exposures to phthalates and folic acid, and autistic traits in Canadian children Environ Health Perspect 2020 128 2 027004 10.1289/EHP5621 32073305
Oulhote Y, Lanphear B, Braun JM, Webster GM, Arbuckle TE, Etzel T, et al. Gestational exposures to phthalates and folic acid, and autistic traits in Canadian children. Environ Health Perspect. 2020;128(2):027004.32073305 10.1289/EHP5621
130. Volk HE Hertz-Picciotto I Delwiche L Lurmann F McConnell R Residential proximity to freeways and autism in the CHARGE study Environ Health Perspect 2011 119 6 873 877 10.1289/ehp.1002835 21156395
Volk HE, Hertz-Picciotto I, Delwiche L, Lurmann F, McConnell R. Residential proximity to freeways and autism in the CHARGE study. Environ Health Perspect. 2011;119(6):873–7.21156395 10.1289/ehp.1002835
131. Rossignol DA Genuis SJ Frye RE Environmental toxicants and autism spectrum disorders: a systematic review Transl Psychiatry. 2014 4 2 e360 10.1038/tp.2014.4 24518398
Rossignol DA, Genuis SJ, Frye RE. Environmental toxicants and autism spectrum disorders: a systematic review. Transl Psychiatry. 2014;4(2):e360.24518398 10.1038/tp.2014.4
132. Dutheil F Comptour A Morlon R Mermillod M Pereira B Baker JS Autism spectrum disorder and air pollution: a systematic review and meta-analysis Environ Pollut 2021 278 116856 10.1016/j.envpol.2021.116856 33714060
Dutheil F, Comptour A, Morlon R, Mermillod M, Pereira B, Baker JS, et al. Autism spectrum disorder and air pollution: a systematic review and meta-analysis. Environ Pollut. 2021;278:116856.33714060 10.1016/j.envpol.2021.116856
133. Dou JF, Schmidt RJ, Volk HE, Nitta MM, Feinberg JI, Newschaffer CJ, Croen LA, Hertz-Picciotto I, Fallin MD, Bakulski KM. Exposure to heavy metals in utero and autism spectrum disorder at age 3: a meta-analysis of two longitudinal cohorts of siblings of children with autism. Environ Health. 2024;23(1):62. 10.1186/s12940-024-01101-2.
134. Ding M Shi S Qie S Li J Xi X Association between heavy metals exposure (cadmium, lead, arsenic, mercury) and child autistic disorder: a systematic review and meta-analysis Front Pediatr 2023 11 1169733 10.3389/fped.2023.1169733 37469682
Ding M, Shi S, Qie S, Li J, Xi X. Association between heavy metals exposure (cadmium, lead, arsenic, mercury) and child autistic disorder: a systematic review and meta-analysis. Front Pediatr. 2023;11:1169733.37469682 10.3389/fped.2023.1169733
135. Lyall K Croen LA Sjödin A Yoshida CK Zerbo O Kharrazi M Polychlorinated biphenyl and organochlorine pesticide concentrations in maternal mid-pregnancy serum samples: association with autism spectrum disorder and intellectual disability Environ Health Perspect 2017 125 3 474 480 10.1289/EHP277 27548254
Lyall K, Croen LA, Sjödin A, Yoshida CK, Zerbo O, Kharrazi M, et al. Polychlorinated biphenyl and organochlorine pesticide concentrations in maternal mid-pregnancy serum samples: association with autism spectrum disorder and intellectual disability. Environ Health Perspect. 2017;125(3):474–80.27548254 10.1289/EHP277
136. Schmidt RJ Kogan V Shelton JF Delwiche L Hansen RL Ozonoff S Combined prenatal pesticide exposure and folic acid intake in relation to autism spectrum disorder Environ Health Perspect 2017 125 9 097007 10.1289/EHP604 28934093
Schmidt RJ, Kogan V, Shelton JF, Delwiche L, Hansen RL, Ozonoff S, et al. Combined prenatal pesticide exposure and folic acid intake in relation to autism spectrum disorder. Environ Health Perspect. 2017;125(9):097007.28934093 10.1289/EHP604
137. von Ehrenstein OS Ling C Cui X Cockburn M Park AS Yu F Prenatal and infant exposure to ambient pesticides and autism spectrum disorder in children: population based case-control study Bmj. 2019 364 l962 10.1136/bmj.l962 30894343
von Ehrenstein OS, Ling C, Cui X, Cockburn M, Park AS, Yu F, et al. Prenatal and infant exposure to ambient pesticides and autism spectrum disorder in children: population based case-control study. Bmj. 2019;364:l962.30894343 10.1136/bmj.l962
138. Román P Ruiz-González C Rueda-Ruzafa L Cardona D Requena M Alarcón R Exposure to environmental pesticides and the risk of autism spectrum disorders: a population-based case-control study Medicina 2024 60 3 479 10.3390/medicina60030479 38541205
Román P, Ruiz-González C, Rueda-Ruzafa L, Cardona D, Requena M, Alarcón R. Exposure to environmental pesticides and the risk of autism spectrum disorders: a population-based case-control study. Medicina. 2024;60(3):479.38541205 10.3390/medicina60030479
139. Goodman CV Green R Dacosta A Flora D Lanphear B Till C Sex difference of pre- and post-natal exposure to six developmental neurotoxicants on intellectual abilities: a systematic review and meta-analysis of human studies Environ Health. 2023 22 1 80 10.1186/s12940-023-01029-z 37978510
Goodman CV, Green R, Dacosta A, Flora D, Lanphear B, Till C. Sex difference of pre- and post-natal exposure to six developmental neurotoxicants on intellectual abilities: a systematic review and meta-analysis of human studies. Environ Health. 2023;22(1):80.37978510 10.1186/s12940-023-01029-z
140. Stamova B Green PG Tian Y Hertz-Picciotto I Pessah IN Hansen R Correlations between gene expression and mercury levels in blood of boys with and without autism Neurotox Res 2011 19 31 48 10.1007/s12640-009-9137-7 19937285
Stamova B, Green PG, Tian Y, Hertz-Picciotto I, Pessah IN, Hansen R, et al. Correlations between gene expression and mercury levels in blood of boys with and without autism. Neurotox Res. 2011;19:31–48.19937285 10.1007/s12640-009-9137-7
141. Ijomone OM Olung NF Akingbade GT Okoh COA Aschner M Environmental influence on neurodevelopmental disorders: potential association of heavy metal exposure and autism J Trace Elem Med Biol 2020 62 126638 10.1016/j.jtemb.2020.126638 32891009
Ijomone OM, Olung NF, Akingbade GT, Okoh COA, Aschner M. Environmental influence on neurodevelopmental disorders: potential association of heavy metal exposure and autism. J Trace Elem Med Biol. 2020;62:126638.32891009 10.1016/j.jtemb.2020.126638
142. Kern JK Geier DA Adams JB Garver CR Audhya T Geier MR A clinical trial of glutathione supplementation in autism spectrum disorders Med Sci Monit 2011 17 12 CR677 10.12659/MSM.882125 22129897
Kern JK, Geier DA, Adams JB, Garver CR, Audhya T, Geier MR. A clinical trial of glutathione supplementation in autism spectrum disorders. Med Sci Monit. 2011;17(12):CR677.22129897 10.12659/MSM.882125
143. Sandin S Schendel D Magnusson P Hultman C Surén P Susser E Autism risk associated with parental age and with increasing difference in age between the parents Mol Psychiatry 2016 21 5 693 700 10.1038/mp.2015.70 26055426
Sandin S, Schendel D, Magnusson P, Hultman C, Surén P, Susser E, et al. Autism risk associated with parental age and with increasing difference in age between the parents. Mol Psychiatry. 2016;21(5):693–700.26055426 10.1038/mp.2015.70
144. Lugo Marín J Alviani Rodríguez-Franco M Mahtani Chugani V MagánMaganto M DíezVilloria E Canal BR Prevalence of schizophrenia spectrum disorders in average-IQ adults with autism spectrum disorders: a meta-analysis J Autism Dev Disord 2018 48 1 239 250 10.1007/s10803-017-3328-5 28980099
Lugo Marín J, Alviani Rodríguez-Franco M, Mahtani Chugani V, MagánMaganto M, DíezVilloria E, Canal BR. Prevalence of schizophrenia spectrum disorders in average-IQ adults with autism spectrum disorders: a meta-analysis. J Autism Dev Disord. 2018;48(1):239–50.28980099 10.1007/s10803-017-3328-5
145. Mutluer T Aslan Genç H Özcan Morey A YapiciEser H Ertinmaz B Can M Population-based psychiatric comorbidity in children and adolescents with autism spectrum disorder: a meta-analysis Front Psychiatry 2022 13 856208 10.3389/fpsyt.2022.856208 35693977
Mutluer T, Aslan Genç H, Özcan Morey A, YapiciEser H, Ertinmaz B, Can M, et al. Population-based psychiatric comorbidity in children and adolescents with autism spectrum disorder: a meta-analysis. Front Psychiatry. 2022;13:856208.35693977 10.3389/fpsyt.2022.856208
146. Wild CP The exposome: from concept to utility Int J Epidemiol 2012 41 1 24 32 10.1093/ije/dyr236 22296988
Wild CP. The exposome: from concept to utility. Int J Epidemiol. 2012;41(1):24–32.22296988 10.1093/ije/dyr236
